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Mixed-effects models are commonly used to model longitudinal data as they can
appropriately account for within and between subject sources of variability. Univariate
mixed effect modeling strategies are well developed for a single outcome (response)
variable that may be continuous (e.g. Gaussian) or categorical (e.g. binary, Poisson) in
nature. Only recently have extensions been discussed for jointly modeling multiple
outcome variables measures longitudinally. Many diseases processes are a function of
several factors that are correlated. For example, the metabolic syndrome, a constellation of
cardiovascular risk factors associated with an increased risk of cardiovascular disease and
type 2 diabetes, is often defined as having three of the following: elevated blood pressure,
high waist circumference, elevated glucose, elevated triglycerides, and decreased HDL.
Clearly these multiple measures within a subject are not independent. A model that could
jointly model two or more of these risk factors and appropriately account for between
subjects sources of variability as well as within subject sources of variability due to the
longitudinal and multivariate nature of the data would be more useful than several
univariate models. In fact, the univariate mixed-effects model can be extended in a
relatively straightforward fashion to define a multivariate mixed-effects model for
longitudinal data by appropriately defining the variance-covariance structure for the
random-effects. Existing software such as the PROC MIXED in SAS can be used to fit the
multivariate mixed-effects model.

xi

The Fels Longitudinal Study data were used to illustrate both univariate and
multivariate mixed-effects modeling strategies. Specifically, jointly modeled longitudinal
measures of systolic (SBP) and diastolic (DBP) blood pressure during childhood (ages two
to eighteen) were compared between participants who were diagnosed with at least three of
the metabolic syndrome risk factors in adulthood (ages thirty to fifty-five) and those who
were never diagnosed with any risk factors. By identifying differences in risk factors, such
as blood pressure, early in childhood between those who go on to develop the metabolic
syndrome in adulthood and those who do not, earlier interventions could be used to prevent
the development cardiovascular disease and type 2 diabetes.
As demonstrated by these analyses, the multivariate model is able to not only
answer the same questions addressed as the univariate model, it is also able to answer
additional important questions about the association in the evolutions of the responses as
well as the evolution of the associations. Furthermore, the additional information gained by
incorporating information about the correlations between the responses was able to reduce
the variability (standard errors) in both the fixed-effects estimates (e.g. differences in
groups, effects of covariates) as well as the random-effects estimates (e.g. variability).

xii
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Introduction

1.1. Introduction
Multivariate longitudinal data occur when multiple measures are collected on the same
individual repeatedly over time. For example, systolic blood pressure (SBP) and diastolic
blood pressure (DBP) measures are collected simultaneously from a patient every time
they visit the doctor’s office. Together these measurements give the physician an
indication of the health and functioning of an individual’s circulatory system at a given
time point, and longitudinal measures of SBP and DBP can alert the physician to changes
in the health of an individual. SBP is the pressure while the heart contracts to pump blood
to the body, while DBP is the pressure when the heart relaxes between beats. Measures of
SBP and DBP are highly related and changes in either often affect changes in the other. A
great deal of interest then lies in how the evolution of SBP is related to the evolution of
DBP, as well as how the association changes, or evolves, over time. A modeling
approach that jointly models longitudinal measures of SBP and DBP over time can lend
insight into these questions.
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1.2. Modeling Longitudinal Data
Longitudinal data are a series of measurements of the same event taken from the same
individual repeatedly over time. The most unique characteristic of longitudinal data is the
ability to directly study change. The primary goal of most longitudinal studies is to
characterize the change in response over time and the factors that influence this change.
Great strides have been made over the past three decades involving development of
statistical methodology for longitudinal data analysis. Longitudinal data require special
methodology because the series of data from one subject are likely intercorrelated, and
this correlation must be taken into account to draw valid statistical inferences. In fact,
longitudinal data usually exhibit a positive correlation, with the strength of the
association decreasing as a function of time separation (i.e. observations further apart as
less correlated than those closer together). The next section will cover some basic
notation.

1.2.1

Some Notation

Focusing briefly on some specific points of notation, let Yij represent a response variable
and let xij be a p × 1 vector of explanatory variables observed at time tij , for
observations i = 1,..., n j on subject j = 1,..., S . The mean and variance of Yij are

( )

( )

represented by E Yij = μij and Var Yij = vij , respectively. The set of repeated

2

(

)

outcomes for the jth subject are collected into an n j ×1 vector, Y j = Y1 j Y2 j ... Yn j ,
j

( )

( )

with mean E Y j = μ j and n j × n j variance-covariance matrix Var Y j = V j , where
the ii′ element of V j is the covariance between Yij and Yi′j , denoted by

(

)

Cov Yij , Yi′j = vii′j . The n j × n j correlation matrix of Y j is denoted by R j . The
responses for all subjects are then collected into the N × N vector
Y = ( Y1 Y2 ... YS ) , with N =

S

∑ n j.
j =1

Most longitudinal analyses are based on a regression model such as the usual
linear model,
Yij = β1xij1 + β 2 xij 2 + ... + β p xijp + ε ij
= xij ′β + ε ij ,

(

)

Where, β = β1 β 2 ... β p is a p × 1 vector of unknown regression coefficients and ε ij is
a zero-mean random variable representing the deviation of the response from the model
prediction xij′β. Typically, xij1 = 1 for all j and i, while β1 is the intercept term in the
linear model.
In matrix notation, the regression equation for the jth subject takes the form

Y j = X jβ + ε j ,

(

)

where X j is an n j × p matrix with xij in the ith row and ε j = ε1 j ε 2 j ... ε n j .
j
3

The following section will cover some general approaches to handling longitudinal data.

1.2.2

General Approaches

Researchers have been collecting longitudinal data for centuries, and have likely been
spending an equal amount of time deriving methods for the analysis of such data. An in
depth historical perspective of the methods for analyzing longitudinal data can be found
in Fitzmaurice (2008) and Ware and Liang (1996). Researchers can use several general
approaches to model longitudinal data, as described by Diggle et al. (2002), Fahrmeir and
Tutz (1994, 2001), and Molenberghs and Verbeke (2006); these are summarized below.
A simple and sometimes effective strategy is to reduce the series of repeated
measures to one (or two) summary measure, and then analyze each summary measure as
a function of the covariates, x j . This “two-stage”, or “derived variable”, analysis dates
back to the early contributions of growth curve analysis by Wishart (1938), Box (1950),
and Rao (1958) and agricultural experiments by Roswell and Walters (1976). The method
is applicable only when the covariates are time-invariant (i.e. xij = x j for all i and j),
since the summary value can only be regressed on x j . However, this approach is less
useful if important explanatory variables change over time. While this approach has
certain appeal due to its simplicity, it has a number of additional drawbacks. Clearly,
there is a considerable loss of useful information. Also, subjects with different profiles
can produce the same summary measures. Finally, some summary measures that have
4

been proposed are not well defined where there are missing data or irregularly spaced
repeated measures. Rather than reduce the series of data to summary measures, there are
three other modeling strategies that can be employed to model the individual Yij as a
function of xij .
The first strategy considered models the marginal mean. The term marginal is
used here to indicate that the model for the mean response at each occasion depends only
on the covariates of interest and not on random effects or previous responses. A marginal
model can be specified using the framework of generalized linear models (GLM) (Nedler
and Wedderburn, 1972). The model is typically specified in three parts. First, the mean of

(

)

each response, E Yij | Xij = μij , is assumed to depend on the covariates through a

( )

known link function, h−1 μij = Xij′β (for example, the logit link for binary responses
or the log link for Poisson responses). Second, the variance of each Yij , given the

(

)

( )

covariates, is assumed to depend on the mean according to Var Yij | Xij = φ v μij ,

( )

where v μij is a known variance function and φ is a scale parameter that may be
known or may need to be estimated. Third, and lastly, the conditional within-subject
association among the vector of repeated responses, given the covariates, is assumed to
be a function of an additional set of association parameters. This approach has the
advantage of separately modeling the mean and covariance. The separation of the model
for the mean response from the model for the within-subject associations ensures that the
5

marginal model regression coefficients have interpretations that do not depend on the
assumptions made about the within-subject associations. Furthermore, valid inference
about β can often still be made even when an incorrect value for V is assumed. There
are limitations of the marginal model that are worth mentioning. While the marginal
model can handle missing data, there are only a limited number of variance-covariance
structures that can handle unbalanced data (i.e. when the data collection time points vary
between subjects.) Also, the marginal model is unable to distinguish between withinsubject and between-subject variability. Liang and Zeger (1986) developed generalized
estimating equations (GEE) to estimate consistent estimators or the regression parameters
in a marginal model, and their variances, under relatively mild conditions. While the
semi-parametric GEE methods have been the dominant methods for estimation of
marginal models, they are certainly not the only approach.
A second strategy which may be implemented for modeling longitudinal data is a
mixed-effects, or random-effects, modeling approach (Laird and Ware, 1982). Here, the
mean response depends not only on the covariates of interest, but also on a vector of
random effects. The idea with this model is that some subset of the regression parameters
vary randomly from one individual to the next, thereby accounting for sources of natural
heterogeneity in the population. Each subject is assumed to have their own subjectspecific mean response trajectory over time and a subset of the regression parameters are
now regarded as being random. The linear mixed-effects model fits the mean response as
a combination of population characteristics (fixed-effects) assumed to be shared by all
6

individuals and subject-specific effects (random-effects) that are unique to a particular
individual. By including random-effects in the model, linear mixed-effects models are
able to explicitly distinguish between within-subject and between-subject sources of
variation. With a linear mixed-effects model it is not only possible to estimate parameters
that describe how the mean responses change over time, but it is also possible to predict
how an individual’s response trajectories change over time. Mixed-effects models are
highly attractive due to their ability to handle missing and unbalanced data reasonably
well.
A third approach for modeling longitudinal data, is often referred to as the
conditional models method. This method works by modeling the mean and the time
dependence simultaneously by conditioning an outcome on other outcomes or on a subset
of other outcomes. The most common example of a conditional model is the classical
log-linear model (Agresti, 2002). A particular case of conditional models is known as the
transition model. Transition models are considered conditional in the sense that they
model the conditional distribution of the response at any point in time, given the previous
responses and the covariates. The dependence in the repeated measures is thought to be
due to the past values influence of the response the present observation. Well known
transition models are Markov type models. There are many examples of the use of
Markov chains to model equally spaced discrete longitudinal data with a finite number of
categories (Anderson and Goodman, 1957; Cox, 1958; Billingsley, 1961). Other
discussions of transition models applied to longitudinal data can be found in Cox (1972),
7

Korn and Whittemore (1979), Zeger et al. (1985), and Ware et al. (1988). While
transition models have a long history of use with longitudinal data, their application has
been limited. In general, transition models have, for the most part, only been developed
for equally spaced repeated measures, and are more difficult to apply with missing data,
mistimed measurements, and non-equidistant intervals between time points. Another
limitation is that estimation of the regression parameters can be highly affected by the
assumptions regarding time dependence. Furthermore, the effects of the covariates may
be diminished when conditioning on past responses.
With all three approaches, both the dependence of the responses on the
explanatory variables and the autocorrelations among the responses are modeled. There
are at least three serious consequences to ignoring inherent correlations in longitudinal
data (Diggle et al. 2002). First, incorrect inferences about the regression coefficients, β,
can be made. Second, estimates of β may be inefficient (i.e. less precise than possible).
Third, there is suboptimal protection against biases caused by missing data.

1.2.3

Modeling Different Types of Longitudinal Data

An important characteristic of longitudinal data is the type of outcome being measured.
Methods for continuous, normally distributed data form the most developed and
advanced body of research spanning the literature from the early works of British
astronomer Airy (1861) through the landmark paper on linear mixed-effects models by
Laird and Ware (1982). Unfortunately, researchers are often confronted with different
8

types of data such as binary, multinomial, or count. One view researchers take, supported
by large sample results, is that normal theory should be used as much as possible, even
with regards to non-normal data such as ordinal scores and counts (Fitzmaurice, et al.,
2009). A more predominant view is that each type of outcome should be analyzed using
methods that exploit the nature of the data.
The GLM described earlier for the marginal models is able to handle any type of
response in the exponential family (i.e. Gaussian, binary, Poisson) and has been extended
to allow for random-effects. In the same sense that the linear model defined in section
1.2.1 is a special case of the GLM, the linear mixed-effects model is a special case of the
generalized linear mixed-effects model (GLMM). In this case, given a vector of randomeffects, the responses are assumed to be conditionally independent and to have
distributions from the exponential family. The conditional mean depends on both fixedeffects and random-effects for some known link function. The conditional variance is
assumed to depend on the conditional mean. Finally, the random-effects are assumed to
be independent of the covariates and to have a zero-mean multivariate normal
distribution. Work by Ashford and Sowden (1970), Pierce and Sands (1975), and Korn
and Whittemore (1979) laid the framework for GLMM’s with much of work that
followed focusing on the issues of estimation. It is worth noting, however, that the
extensions to GLMM’s can have important implications for the interpretation of the
regression coefficients. In GLMM’s, the regression coefficients have subject-specific
interpretations and represent the effects of the covariates on changes in an individual’s
9

(possibly transformed) mean response per unit change in the covariate (Molenberghs and
Verbeke, 2006; Fitzmaurice et al., 2009). With marginal models, on the other hand, the
regression coefficients have population based interpretations and represent the effects of
covariates on changes in the population’s (possibly transformed) mean response per unit
change in the covariate. In the special case of the linear model, where an identity link
function is assumed, the fixed-effects in the model for the conditional mean also happen
to have interpretations in terMs of the population means.
The GLM has also been extended to handle most types of conditional transition
models and many of the previously cited literature deals with non-Gaussian data. An
extensive discussion on the extensions can be found in Molenberghs and Verbeke part III
(2006).

1.3. Modeling Joint Longitudinal Data
When there are multiple outcomes measured repeatedly over time, the most basic
approach would be to model each longitudinal outcome independently. However, this
does not account for the multivariate nature of the data. As compared to traditional
univariate approaches, methods for analyzing multivariate longitudinal data can be
challenging for several reasons. For one, the variability for each response is likely to be
different. Also, in addition to the correlation due to repeated measures over time, there is
likely to be correlations between the outcomes. The primary objective of joint modeling
is to provide a framework where questions of scientific interest pertaining to relationships
10

among and between the multiple outcomes and other factors (i.e. treatment, dose, or
covariates) may be formalized. In order for there to be valid inference, the joint models
must be able to appropriately account for correlations within and between each outcome.
General approaches to what has been discussed thus far, will be cover next.

1.3.1

General Approaches

Consider modeling two outcomes Y1 and Y2 , where one, or both, may have been
collected longitudinally. Here, attention will be restricted to two outcomes, noting that
extensions for more than two outcomes are relatively straightforward. There are several
methods available in the literature for jointly modeling longitudinal data. Four of these
are briefly discussed below, while more thorough descriptions can be found in recent
texts by Fitzmaurice et al. (2009) and Molenberghs and Verbeke (2006).
One strategy is referred to as the multivariate marginal models (Galecki, 1994;
Molenberghs and Verbeke, 2006). The idea here is to directly specify the joint density

f ( y1, y 2 ) of ( Y1, Y2 ) . The model includes the necessary assumptions about the
marginal association among the longitudinal measurements within each vector
Y1 and Y2 , as well as assumptions of the nature of the associations between elements of
Y1 and Y2 . This may become difficult if Y1 and Y2 are of different types (e.g.
continuous and binary, or continuous and time-to-event) or in the case of highly
unbalanced data. Furthermore, extensions beyond two outcomes are especially
11

challenging since assumptions about larger, more complex association structures must be
made. The primary attraction to this model is the ability to directly make inferences about
the marginal characteristics of the outcomes (e.g. average evolutions).
A second strategy is the conditional model described in section 1.2.2. Here, direct
specification of a joint distribution for ( Y1, Y2 ) is avoided by factorizing the density into
a product of a marginal and a conditional density. That is,

f ( y1, y2 ) = f ( y1 | y2 ) f ( y2 ) = f ( y2 | y1 ) f ( y1 ) .
This reduces the problem to specifications of the models for each of the outcomes
separately, with a marginally specified model for one outcome, and a conditionally
specified model for the other. Careful attention must be given to the choice of which
outcome is modeled marginally and which is modeled conditionally. For example, it may
be plausible that one plays the role of a time-dependent covariate. Different choices can
lead to very different, and perhaps opposite, results and conclusions. Another limitation
with this methodology is that it does not directly lead to marginal inferences. Finally,
when both outcomes are highly correlated and thought to be manifestations of a common
underlying treatment effect, conditioning on one will attenuate the treatment effect of the
other. Therefore, conditional models are not the preferred approach when there are more
than two outcomes since there may be many more possible factorizations. Examples of
conditional models used to jointly model a continuous and binary outcome can be found
in Tate (1954), Olkin and Tate (1961), Little and Schluchter (1985), Krzanowski (1988),
and Cox and Wermuth (1992, 1994).
12

A third strategy is the shared-parameters modeling approach. As described earlier,
random-effects can be introduced into a model to account for associations in the
longitudinal measures. This same idea can be extended to account for additional
associations in the multivariate longitudinal data. For the shared-parameters model,
define β as a vector of random-effects, common to the model for Y1 and the model for
Y2 , and assume independences of both outcomes, conditionally on β . The joint density
of ( Y1, Y2 ) is then obtained from
f ( y1, y2 ) = ∫ f ( y1, y2 | β ) f ( β )dβ = ∫ f ( y1 | β ) f ( y2 | β ) f ( β ) dβ,

where f ( β ) denotes the marginal density of the random effects. In this formulation, the
random-effects, β, is a “shared-parameter” that induces a correlation between Y1 and Y2
through their joint dependence of β. That Y1 and Y2 are conditionally independent
given the random-effects, β, is interpreted as a belief that a common set of underlying
characteristics of the individual governs both outcome processes. An advantage of this
type of model is that Y1 and Y2 do not need to be of the same type (e.g. Y1 could be
continuous responses and Y2 could be binary responses). Another advantage is that the
parameters in the joint shared-parameters model have the same interpretations as they do
in each of the corresponding “univariate” models. In addition, extensions for more than
two outcomes are straightforward and because dimensionality in the above integration
does not increase, computational intensity does not increase. This type of model has been
13

used repeatedly in the literature to jointly model a longitudinal outcome and a time-toevent outcome (Degruttola and Tu, 1994; Tsiatis et al., 1995; Faucett and Thomas, 1996;
Tsiatis and Davidian, 2004). The main disadvantage of the shared-parameters approach is
that it implies very strong assumptions about the association between the outcomes being
modeled. Specifically, the correlation between pairs of measurements from different
outcomes must be equal to the product of the correlation between measurements from the
first outcome and measurements from the second outcome (Fitzmaurice et al., 2009).
That is,

Corr {Y1( s), Y2 (t )} = Corr {Y1( s ), Y1(t )} Corr {Y2 ( s ), Y2 (t )}.
As such, the shared-parameter model may not accurately represent the association
structure of the data. This motivated the need for more flexible correlation patterns, at the
expense of model complexity.
A fourth, and final, approach is the random-effects model method. The
assumptions in the correlation structure in the shared parameters model could be relaxed
by allowing the models for Y1 and Y2 to depend on separate vectors of the randomeffects parameters, β1 and β 2 , which are theMselves correlated. Under these
assumptions,

Corr {Y1( s), Y2 (t )} ≤ Corr {Y1( s), Y1(t )} Corr {Y2 ( s), Y2 (t )}.
Random-effects models can easily be extended to model more than two outcomes,
however, the dimensionality of the vector of random-effects increases as the number of
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outcomes increases, leading to computational difficulties. Pair-wise modeling approaches
may be a more appropriate means to side-step the issue of dimensionality (Verbeke et al.,
2006).

1.3.2

Choosing Between the Univariate Models and a Multivariate Model

The availability of the joint model does not necessarily mean that a researcher must use
one. It is possible that several univariate models will suffice to answer the research
question, or questions, at hand. In other cases, it is necessary to combine all of the
responses into a single model in order to draw specific inferences. Sometimes, the
association structure may be of direct importance. For example, a researcher may be
interested in how the changes in one response are associated with changes in another
response (the association in the evolution). There may also be interest in how the
association between the responses changes or evolves over time (the evolution in the
associations). Analyses pertaining to these questions have been described in Fieuws and
Verbeke (2004, 2006) in bivariate and multivariate settings. A joint model would also be
necessary if a researcher were interested in testing fixed-effects referring to a set of
outcomes simultaneously. For example, the definition of success of an intervention may
depend on more than one response variable. Joint models may also have addition benefits
for predication purposes. Furthermore, the additional information from multiple
outcomes may better discriminate between groups (Fieuws et al., 2007). When outcomes
share parameters, a joint model can lead to a gain in efficiency. Even when all parameters
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are outcome-specific, there is a potential gain in efficiency when there are missing data.
For example, one may be able to assume the data are missing at random in a multivariate
model, but not be able to do so when looking at each outcome separately.

1.4. The Metabolic Syndrome
The primary focus of this thesis is to jointly model two continuous outcomes as a
function of fixed-effects and random-effects. More specifically, there is interest in
modeling longitudinal measures of childhood SBP and DBP, as a function of birth weight
and physical maturation, to determine if there exist differences in the childhood profiles
between those who go on to develop the metabolic syndrome later in life and those who
never develop any of the risk factors associated with the metabolic syndrome. The
following sections give a definition of the metabolic syndrome and describe the
measurement procedures for the risk factors associated with this syndrome, along with a
more formal definition of the purpose of this thesis.

1.4.1

Diagnosis of the Metabolic Syndrome

The metabolic syndrome, which is a constellation of cardiovascular risk factors, has also
been referred to as syndrome X (Raven, 1993), the “deadly quartet” (Kaplan, 1989),
insulin resistance syndrome (Stern., 1994), and hypertriglyceride waist (Lemieux, et al.,
2000), and has been defined by several major organizations over the years. The term,
metabolic syndrome, is most commonly used in the cardiovascular field. The metabolic
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syndrome has been receiving increased attention over the past years in part due to its
promotion of atherosclerotic cardiovascular disease (ASCVD). The metabolic syndrome
is generally classified as a “constellation of interrelated risk factors of metabolic origin-metabolic risk factors--that appear to directly promote the development of atherosclerotic
cardiovascular disease” (Grundy, et al., 2005). Furthermore, it has been proposed that not
only is the metabolic syndrome related to ASCVD, but the risk for ASCVD associated
with the metabolic syndrome risk factors is more than the sum of its parts (Grundy,
2006). There is also a relationship between the metabolic syndrome and an increased risk
of developing type 2 diabetes mellitus (Grundy, et al., 2005). Both ASCVD and type 2
diabetes mellitus are growing health concerns that plague numerous Americans as the
prevalence of obesity grows in the United States. The Center for Disease Control and
Prevention defines obesity for an individual as that person having a body mass index
(BMI) of thirty or greater (note, BMI is calculated from a person’s weight and height and
provides a reasonable indicator of body fatness and weight). In 2008, the CDC
determined that forty-nine states in America had a prevalence of obesity of more than
20%. These numbers also appear to be on the rise. The metabolic syndrome takes into
account risk factors other than just BMI, making it a potential barometer of future
medical comorbities related to ASCVD and type 2 diabetes mellitus.
Given the hefty suMs of money spent each year on health probleMs associated
with the metabolic syndrome, ASCVD, and type 2 diabetes mellitus, it is of great interest
to investigate methods for the early prediction for the metabolic syndrome. Not only is
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obesity on the rise amongst the general U.S. population, it is also on the rise amongst
children. According to a July report by the National Center for Health Statistics, 15% of
children ages six to eighteen were overweight in 2000, this percentage is up from just 6%
in 1980. Given these alarming numbers regarding the prevalence of obesity in children, it
is desirable to investigate a predictive model that would be capable of identifying
children who are at increased risk of developing the metabolic syndrome as adults. Early
detection is can be important in combating most health related probleMs an individual
may develop. Therefore, identifying those between the ages of two and eighteen who
may be at increased risk to develop the metabolic syndrome as adults is of significant
interest in the early detection and prevention of cardiovascular disease and type 2
diabetes.
Though, many proposals have been made in the past decade to best define what
set of criteria determines if an individual has the metabolic syndrome, only one will be
considered for the purposes of this analysis; the National Cholesterol Education Program
(NCEP) Adult Treatment Panel III (ATP III) criteria. Historically, the two underlying risk
factors that appear to be most serious are abdominal obesity (Lemieux et al., 2000) and
insulin resistance (Park et al., 2003). Many other possible associated factors have been
considered over the years including physical inactivity (Gustat et al., 2002), aging (Ford
et al., 2002), and hormonal imbalance (Apridonidze, et al, 2004).
Despite the numerous definitions proposed over the years since the metabolic
syndrome was first proposed as a medical diagnosis, the definition which will be
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considered for the purposes of this thesis is that proposed in 2001 by the NCEP ATP III.
This was the first proposed definition that did not specifically required documentation of
an elevated insulin resistance, noting that direct measures of insulin resistance are
laborious and not well standardized (Grundy et al. 2005). Since the ATP III criteria for
the metabolic syndrome removed the requirement of insulin resistance, there was now no
single factor necessary for diagnosis. Instead, five risk factors are considered under the
ATP III criteria, they are as follows: elevated waist circumference, reduced HDL-c,
elevated serum glucose, elevated triglycerides, and elevated blood pressure. The presence
of at least three out of the aforementioned five risk factors is the basis for diagnosing the
metabolic syndrome under the ATP III proposal. The ATP III criteria for the metabolic
syndrome will be used given that it is the most simple to use in a clinical setting and also
has the benefit of not emphasizing a single risk factor. So, in summary, the metabolic
syndrome shall be defined here as having any three of the five risk factors in accordance
with the ATP III criteria.
For each risk factor outlined by the ATP III criteria, there is a categorical cut
point, for certain risk factors these are the same for males and females, for other risk
factors the cut points are different. If an individual falls above (or below in the case of
HDL-c) this cut point, they are considered to have that particular risk factor. These cut
points are laid out in Table 1, which is followed by a more detailed definition of each risk
factor.
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Table 1: ATP III Criteria Categorical Cut Points for the Metabolic Syndrome
Male
Female
Waist Circumference
≥ 102 cm ( ≥ 40 inches)
≥ 88 cm ( ≥ 35 inches)
HDL-c
< 40 mg/dL (1.03 mmol/L)
< 50 mg/dL(1.3 mmol/L)
Serum Glucose
≥ 100 mg/dL
Triglycerides
≥ 150 mg/dL (1.7 mmol/L)
Systolic Blood Pressure
≥ 130 mm Hg
Diastolic Blood Pressure
≥ 85 mm Hg
Having either SBP or DBP ≥ the cut point, means having the blood pressure risk factor
First considering the risk factor of waist circumference, literature pertaining to the
metabolic syndrome gives the following recommendation for waist measurement:
“…locate top of right iliac crest. Place a measuring tape in a horizontal plane around the
abdomen at level of iliac crest.” (Grundy et al., 2005). The second metabolic syndrome
risk factor, fasting serum glucose, is measured by collecting a serum sample for
measuring glucose after an individual has abstained from food for a set period of time.
Fasting triglycerides are measured using a simple standardized blood test know as a
lipoprotein panel; which is used to determine an individual’s triglyceride levels as well as
their cholesterol levels. From the lipoprotein panel HDL-c, the “good cholesterol”, which
carries cholesterol from the body’s tissues to the liver, and can protect against heart
attack and stroke, is measured (recall, HDL-c is the only metabolic syndrome risk factor
with a minimum categorical cut point). Finally, blood pressure, determined by measures
of SBP and DBP, make up the fifth metabolic syndrome risk factor. The systolic blood
pressure measurement is a measure of the peak pressure in the arteries, while the diastolic
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blood pressure is a measurement of the minimum pressure in the arteries. One specific
instrument used to measure blood pressure is a standard mercury sphygmomanometer.

1.5. Jointly Modeling Risk Factors of the Metabolic Syndrome over Time
Now that both the metabolic syndrome and the methodology for analyzing joint
longitudinal data have been introduced, the statistical and biological questions of interest
can be better described. It is of interest to see if those individuals who develop the
metabolic syndrome in adulthood and those who develop no risk factors in adulthood,
have significantly different SBP and DBP profiles during childhood. The question will be
addressed separately for males and females. These models will adjust for both timeinvariant (e.g. sex and birth weight) and time-variant (physical maturation) covariates.
Furthermore, it is of interest to consider both univariate mixed-effects models designed to
handle each outcome measure individually and a single multivariate mixed-effects model
with a multivariate outcome representation.
This analysis will probe the differences between multiple univariate models and a
single multivariate model, allowing discussion between the pros and cons of both
methods, as well what may be gained, or lost, using one versus the other. The metabolic
syndrome is ideal for this type of analysis given it is inherently a syndrome comprised of
multiple outcomes, lending itself to a multivariate mixed-effects model.
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2

Methodology

2.1. Introduction
In this chapter, the methods for modeling longitudinal data with a univariate normal
mixed-effects (random-effects) model are discussed, along with the methods for jointly
modeling multivariate longitudinal data. For the purposes of this thesis, the terMs mixedeffects and random-effects will be used interchangeably, and are considered to be the
same. In section 2.2, the univariate normal random-effects model is introduced and
defined, along with the notation which will be used henceforth. In section 2.3, a
discussion of estimation in normal mixed-effects models is presented. The joint mixedeffects model will be presented in section 2.4, with subsequent sections focusing on
special cases of the G matrix, the association of the evolutions, and the evolution of the
association.
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2.2. Univariate Normal Mixed-Effects Model Definition
The normal random-effects model introduced by Laird and Ware (1982) can be written as
y = Xα + Zβ + ε,

(2.1)

where
y is the N × 1 vector of observed response values,

α is the P × 1 vector of fixed-effects parameters,
X is the N × P observed design matrix corresponding to the fixed-effects,
β is the Q × 1 vector of random-effects parameters,

Z is the N × Q observed design matrix corresponding to the random-effects, and

ε is the N × 1 vector of residuals.
A corresponding assumption of model (2.1) is, β ~ NQ (0, G ) ; that is β has a Q-variate
normal density with mean vector 0 and a variance-covariance matrix G. Furthermore, we
assume β is independent of the vector of residuals, ε , where ε ~ N N (0, R ) ; that is ε has
an N-variate normal density with mean vector 0 and variance covariance matrix R. Given
the assumptions listed above, y~ N N ( Xα, V ) ; that is y has a N-variate normal density
with mean vector Xα and variance-covariance matrix V. For the above, note that

V = Var [ y ] = Var [ Zβ] + Var [ε ] = ZGZ`+R .

23

2.3. Estimation in the Normal Random-Effects Model
In this section, the methods used for estimation in the normal random-effects model,
described above in section 2.2, are discussed. Section 2.3.1, will cover the likelihood
function and approaches to its maximization, more specifically the maximum likelihood
method and the residual maximum likelihood method. The subsequent three sections will
cover estimation of the fixed-effects parameters, random-effects parameters, and variance
parameters.

2.3.1

Methods of Estimation

Suppose a random sample of N observations is obtained from a univariate normal
random-effects model as defined in equation (2.1), then the likelihood of the model
parameters, given the vector of N observations, is defined as

⎧ 1
⎫
exp ⎨− ( Y − Xα ) 'V −1 ( Y − Xα ) ⎬
⎩ 2
⎭,
L = L ( α, γ;y ) =
( 2π )(1/2) N V (1/2 )

(2.2)

where α is a vector of fixed-effects parameters and γ is a vector containing the variance
parameters. Given its simplicity in comparison to the likelihood function, the log of the
likelihood function is generally used in practice. Its maximum value coincides with that
of the likelihood function. The log-likelihood of the model parameters, is defined as
N
1
1
log ( 2π ) − log V − ( Y − Xα ) 'V −1 ( Y − Xα )
2
2
2
1
= K − ⎡log V + ( Y − Xα ) 'V −1 ( Y − Xα ) ⎤ .
⎥⎦
2 ⎢⎣
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l = l ( α, γ;y ) = −

(2.3)

1
where, K = − N log ( 2π ) , which is a constant that may be ignored in the maximization
2

process. Now the values in the model parameters which maximize the log-likelihood may
be determined. Estimates of the parameters for the model given in equation (2.1) are
found by maximizing the log-likelihood given in equation (2.3) with respect to α and γ .
One such method that may be used to maximize the log-likelihood function is the
maximum likelihood (ML) method. The ML method, first maximizes the log-likelihood
with respect to the variance parameters, while treating the fixed-effects parameters, α , as
constant. Upon determining the variance parameter estimates, the fixed-effects
parameters are then determined by finding the values of α which maximize the loglikelihood, while treating the variance parameters as constant. It is important to note, the
maximum likelihood approach may produce variance parameters that are biased
downwards since they are based on the assumption that the fixed-effects parameters are
known (Brown and Prescott, 2006).
Another method that may be used to maximize the log-likelihood function is the
residual maximum likelihood (REML) method. Sometimes this method is referred to as
the restricted maximum likelihood method. For this approach, the fixed-effects
parameters, α , are eliminated from the log-likelihood equation, such that it will only be
defined in terMs of the variance parameters. Then, a likelihood function based on the full

(

)

residuals, ( y − Xαˆ ) , instead of the ordinary residuals, y - Xαˆ - Zβˆ needs to be
determined. It may be noted that the full residuals are a linear combination of y and
25

furthermore ( y − Xαˆ ) and α̂ are independent (Diggle et al., 1994). From these facts, the
joint-likelihood for α and the variance parameters, γ , may be express as a product of the
likelihoods based on ( y − Xαˆ ) and αˆ

ˆ γ ).
L ( γ,α;y ) = L ( γ;y - Xαˆ ) L ( α;α,

(2.4)

Thus,
L ( γ;y - Xαˆ ) =

L ( γ,α;y )
.
ˆ γ)
L ( α;α,

(2.5)

From the above, and equation (2.2),
L ( γ,α;y ) ∝ V

−1

⎧ 1
⎫
exp ⎨− ( y − Xα ) 'V −1 ( y − Xα ) ⎬ .
⎩ 2
⎭

(2.6)

Furthermore, α̂ , has a multivariate normal distribution with mean and variance given by
the maximum likelihood estimates discussed later in equations (2.11), and (2.12),
respectively. Hence,
1
1
ˆ γ ) ∝ X'V -1X 2 exp ⎧⎨ ( αˆ − α ) 'X'V −1X ( αˆ − α ) ⎫⎬ .
L ( α;α,
⎩2
⎭

(2.7)

Taking the ratio of equations (2.6) and (2.7), yields the REML, defined as
L ( γ;y - Xαˆ ) ∝ X'V −1X

−1

2 V − 1 2 exp ⎧− 1 y − Xαˆ 'V −1 y − Xαˆ ⎫ .
)
(
)⎬
⎨ (
⎩ 2
⎭

(2.8)

Therefore, the REML log-likelihood is defined as
−1
⎫⎪
1 ⎧⎪
log L ( γ;y - Xαˆ ) = K − ⎨log V − log X'V −1X + ( y − Xαˆ ) 'V −1 ( y − Xαˆ ) ⎬ . (2.9)
2 ⎩⎪
⎭⎪
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Despite α̂ appearing in the REML log-likelihood in equation (2.9), it is present only as a
function of the variance parameters. As with the maximum likelihood method, the
variance parameters are now estimated by maximizing the REML log-likelihood given in
equation (2.9), with regards to the variance parameters. Given the nature of the REML
likelihood, and its treatment of the fixed-effects as parameters, rather than as constants,
the resulting variance parameter estimates are unbiased. In the same fashion of the
maximum likelihood method, values of α are found by maximizing the REML loglikelihood with regards to the fixed-effects parameters, while treating the variance
parameters as fixed.

2.3.2

Estimation of Fixed-Effects Parameters

For both the maximum log-likelihood method and the REML log-likelihood methods the
fixed effects solutions may be calculated by maximizing either likelihood by
differentiating the log-likelihood with respect to α , and subsequently setting the resulting
expression to zero. That is,
X'V −1 ( y − Xα ) = 0.

(2.10)

The solutions to this equation are the maximum likelihood estimates for the fixed-effects
parameters:

(

αˆ = X'V −1X

)

The variance of α̂ is given by,
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−1

X'V −1y.

(2.11)

(
)
(
)
−1
−1
= ( X'V −1X ) X'V −1VV −1X ( X'V −1X )
−1
= ( X'V −1X ) .

var [αˆ ] = X'V −1X

−1

X'V −1 var [ y ] V −1X X'V −1X

−1

(2.12)

This expression assumes that V is known when in fact V is estimated. Thus there may be
some downward bias in the variance of α̂ , although this is usually small (Brown and
Prescott, 1999).

2.3.3

Estimation of Random-Effects Parameters

Recall, β , the Q × 1 vector of random-effects, is assumed to follow a Q-variate normal
distribution with mean vector 0 and variance-covariance matrix G , β ∼ N Q ( 0, G ) . The
specific values of the random-effects must be thought of as realizations of a sample from
a distribution. Therefore their expected values are zero, by definition. However, it is
possible to obtain predictions (“estimates”) of them. To obtain these estimates, a joint
likelihood function in terMs of α , β , and γ is defined. This is expressed by taking the
product of the likelihoods for y | β and β as

L ( α, β, γ; y ) = L ( α, γ R ; γ | β ) L ( γ G ; β ) .

(2.13)

The likelihood of β is written as
L ( γ G ; β ) = ( 2π )

−Q

⎧ 1
⎫
−1
2 G 2 exp ⎨ − ( β ) 'G ( β ) ⎬ .
⎩ 2
⎭
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(2.14)

The likelihood for y | β is written as

(

1
⎧ 1
L ( α, γ R ; y | β ) ∝ R − 2 exp ⎨− ( y − Xα − Zβ ) 'R −1 ( y − Xα − Zβ )
⎩ 2

)⎭⎫⎬.

(2.15)

Therefore, the joint likelihood for α , β , and γ is defined as
L ( α , β, γ ; y ) ∝ R

−1

2 G

− 1 exp ⎧ 1 ⎡
−1
−1 ⎤ ⎫
2
⎨− ⎢( y − Xα − Zβ ) 'R ( y − Xα − Zβ ) + β'G β ⎥ ⎬ . (2.16)
⎦⎭
⎩ 2⎣

From equation (2.16) the corresponding log-likelihood is expressed as
l ( α , β, γ ; y ) ∝ −

{

}

1
1
log R + log G } − ( y − Xα − Zβ ) 'R −1 ( y − Xα − Zβ ) + β'G −1β . (2.17)
{
2
2

To obtain the maximum likelihood solution for the random-effects parameter, β , the
derivative of the log-likelihood, or REML log-likelihood, is taken with respect to β , and
the subsequent expression is set to zero. That is,

∂l ( α, β, γ; y )
∂β

= Z'R −1 ( y − Xα − Zβ ) − G −1β

(

)

= Z'R −1 ( y − Xα ) − Z'RZ + G −1 β.
Setting the above expression to zero and using the fact that V = ZGZ' + R ,
yields the maximum likelihood solution for βˆ .
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(2.18)

(

βˆ = Z'R −1Z + G −1

)

(

−1

Z'R −1 ( y − Xα )

) (

)

−1
−1 ⎤
⎡
RZ'−1 ⎥ ( y − Xα )
= ⎢ Z'R −1Z + G −1
⎢⎣
⎥⎦
−1
= ⎡ RZ'−1 Z'R −1Z + G −1 ⎤ ( y − Xα )
⎢⎣
⎥⎦
−1
= ⎡ Z + RZ'−1G −1 ⎤ ( y − Xα )
⎣⎢
⎦⎥

(

)(

)

(2.19)

−1
= ⎡( V − R ) Z'−1G −1 + RZ'−1G −1 ⎤ ( y − Xα )
⎣⎢
⎦⎥
= ⎡ VZ'−1G −1 ⎤
⎣⎢
⎦⎥

−1

( y − Xα )

= GZ'V −1 ( y − Xα ) .

The variance of β̂ is given by
var ⎡⎣βˆ ⎤⎦ = GZ'V −1 var [ y − Xα ] V −1ZG

(

)

−1
⎡
⎤
X'V −1y ⎥ V −1ZG
= GZ'V −1 var ⎢ y − X X'V −1X
⎣⎢
⎦⎥

(

)

⎡⎛
−1
⎞ ⎤
= GZ'V −1 var ⎢⎜ I − X X'V −1X
X'V −1 ⎟ y ⎥ V −1ZG
⎟ ⎥
⎢⎣⎜⎝
⎠ ⎦

(

)

(

)

−1
−1 ⎤ −1
⎡
⎤ ⎡
= GZ'V −1 ⎢I − X X'V −1X
X'V −1 ⎥ V ⎢I − V −1X X'V −1X
X'⎥ V ZG
⎢⎣
⎥⎦
⎦⎥ ⎣⎢
−1
−1 ⎤ −1 ⎡
⎤
⎡
X'V −1ZG ⎥
= ⎢GZ' − GZ'V −1X X'V −1X
X'⎥ V ⎢ ZG − X X'V −1X
⎢⎣
⎥⎦
⎢⎣
⎥⎦
−1
= GZ'V −1 − GZ'V −1X X'V −1X
X'V −1ZG.

(

(

)

(

)
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)

(2.20)

Once again, the variance of β̂ will tend to have a small downward bias since it is
assumed that V is known (Brown and Prescott, 1999).

2.3.4

Estimation of Variance Parameters

The variance parameters are also obtained by maximizing the log-likelihood function.
The derivatives of the log-likelihood functions with respect to the variance parameters,
however, are nonlinear. Thus, an iterative approach, such as the Newton-Raphson
algorithm, is often used to find the maximum likelihood solutions. Variance-covariance
estimates of the variance parameters for any given structure can also be obtained by using
large sample theory. These estimates are based on asymptotic theory and should be
interpreted with caution.

2.4. Multivariate Methods
The mixed-model in equation (2.1) can be easily extended to include multiple response
variables by further stacking the data and defining a specific variance-covariance
structure for the random effects. For simplicity consider modeling two response variables
( Y1 and Y2 ) over time and incorporating random intercepts and slopes in order to model
the correlations over time between responses.
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2.5. Multivariate Normal Random-Effects Model Definition
Let yijk represent the ith observation, from the jth subject, for the kth response variable,
where i = 1, …, n jk , j = 1, …, S, and k = 1, …, K. Also, define N k =

N=

K

∑ Nk . The vector Y jk = ⎡⎢⎣ y1 jk

k =1

y2

jk

S

∑ n jk

and

j =1

′
... yn jk ⎤ then represents the n jk
jk ⎥⎦

observations of the kth response variable from the jth subject and the vector

Yk = [ Y1k

Y2k

... YSk ]′ represents the Nk observations for the kth response

variable across all subjects. Finally, the vector Y = [ Y1 Y2 ... Yk ]′ represents the N
observations across all response variables and subjects.
In the context of modeling two response variables, the linear mixed-effects
models for each response variable for subject j taken at time t can be specified as
Y j1 ( t ) = μ1 ( t ) + a j1 + b j1 ( t ) + ε j1 ( t )
Y j 2 ( t ) = μ2 ( t ) + a j 2 + b j 2 ( t ) + ε j 2 ( t )

(2.21)

where μk ( t ) refers to the average evolution (of the kth response over time) and is a
function of the fixed effects. The subject specific random intercepts a jk and slopes
b jk ( t ) describe how the subject specific profiles deviate from the average profile for the
kth response. The two response trajectories are joined together by assuming a joint
distribution for the vector of random-effects, β , such as
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⎡ a j1 ⎤
⎢
⎥
⎢ b j1 ⎥
β=⎢
⎥ ∼ N ( 0, G ) ,
⎢a j 2 ⎥
⎢b ⎥
⎣ j2 ⎦
where the variance-covariance matrix for the random effects, G, has the following
structure:
⎡ σ2
σa b σa a
11
1 2
⎢ a1
⎢
⎢ σb a
σ2
σb a
1
1
1 2
b1
⎢
G=
⎢
2
⎢σ a2 a1 σ a2b1 σ a
2
⎢
⎢σ
b a σ b2b1 σ b2 a2
⎣⎢ 2 1

σa b ⎤

12⎥
⎥
σb b ⎥
12⎥
.
⎥
σa b ⎥
2 2
⎥
2
⎥
σ
b2 ⎦⎥

(2.22)

The error components for each response, which are independent of the random effects,
can be taken to be correlated or uncorrelated ( σ12 = 0 ), such that the error components
are defined as;
⎛
⎡ 2
⎤⎞
⎡ ε1i ⎤
⎜ ⎡0 ⎤ ⎢ σ1 σ12 ⎥ ⎟
.
⎢ε ⎥ ∼ N ⎜ ⎢0 ⎥ , ⎢
⎥⎟
2
⎣
⎦
⎣ 2i ⎦
⎜
⎟
⎣⎢σ 21 σ 2 ⎦⎥ ⎠
⎝

Assuming σ12 = 0 implies that, conditional on the random-effects, both response
trajectories are independent. The assumption of conditional independence could
alternatively be relaxed and the random errors could be taken to be dependent by
allowing for a nonzero covariance between the error components (σ12 ≠ 0 ) .
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2.5.1

Special Cases for the G Matrix

Special case can now be obtained by making specific assumptions for the variancecovariance matrix G. Two such specific variance-covariance structures are described in
the following subsections, a complete independence structure and a shared-parameters
structure.

2.5.1.1 Complete Independence
The two response variable could be taken to be completely independent at any point in
time, thereby imposing the following structure for G:
⎡ σ2
0
σa b
11
⎢ a1
⎢
⎢σ b a
0
σ2
1
1
b1
⎢
G=
⎢
0
σ2
⎢ 0
a2
⎢
⎢ 0
0
σ b2a2
⎣⎢

⎤
⎥
⎥
0 ⎥
⎥.
⎥
σ a2b2 ⎥
⎥
2
⎥
σ
b2 ⎦⎥
0

Within a response variable, the random intercept and slope induce within-subject
correlations in the repeated measures over time, while assuming independence between
subjects. Moreover, this model assumes that the two responses are completely
independent. The results for the model would be identical, in theory, to fitting two
separate random-effect models.
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2.5.1.2 Shared-Parameters
Now that a complete independence structure has been considered for the G matrix one
may consider the other end of the spectrum where the two response variables could be
taken to be completely dependent. In this case, the two responses essentially “share” the
same set of random effect parameters (intercept and slope). When two parameters are
completely dependent, the correlation between them is equal to one. This occurs when
the covariance between the parameters is equal to the square root of the product of their
respective variances. Most notation, however, define the model with a 2 × 1 vector of
random effects, such as
⎡σ2 σ ⎤
⎡a j ⎤
a
ab ⎥
.
β = ⎢ ⎥ ∼ N ( 0, G ) , with G = ⎢
2⎥
⎢σ
σ
⎣⎢ b j ⎦⎥
b ⎦
⎣ ba

Clearly, the aforementioned structure imposes strong assumptions on the relationship
between the two response variables. It is very unlikely that the two responses would
exhibit complete dependence in the association between the random slopes and between
the random intercepts. One advantage of this model, when the assumption is tenable, is
that it drastically reduces the number of random effects that must be estimated when the
number of response variables is large. For models with a large number of response
variables, estimation would likely be impossible if the shared-parameters (or alternative
approach) were not used.
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2.5.2

Association of the Evolutions (AOE)

One important question that may be addressed with a joint mixed-effects model is how
the evolution of one response is associated with the evolution of another response
(“association of the evolutions”). By definition, the correlation between the evolutions for
the two random slopes is given by
rE =

Cov ( b1, b2 )

Var ( b1 ) Var ( b2 )

=

σ b ,b
1 2
σ2 σ2
b1

.

(2.23).

b2

It may be noted that the above expression is produced using those values from the G
matrix defined in equation (2.22).

2.5.3

Evolution of the Association (EOA)

A similar idea that may be investigated using a joint mixed effects model is how the
association between the responses evolves over time (“evolution of the association”).
Assuming uncorrelated errors, the marginal correlation between the two responses as a
function of time is given by
rM ( t ) =

=

(

Cov Y j1 ( t ) , Y j 2 ( t )

(

Var Y j1 ( t )

)

(

)

Var Y j 2 ( t )

)

σ a , a + tσ a ,b + tσ a ,b + t 2σ b ,b
1 2
1 2
2 1
1 2
σ 2 + 2t 2σ a ,b + 2t 2σ 2 + σ12 σ 2 + 2t 2σ a ,b + 2t 2σ 2 + σ 22
1 1
2 2
a1
b1
a2
b2
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(2.24)
.

Assuming correlated errors, the marginal correlation between the two responses as a
function of time is given by
rM ( t ) =

=

(

Cov Y j1 ( t ) , Y j 2 ( t )

(

Var Y j1 ( t )

)

(

)

Var Y j 2 ( t )

)

σ a , a + tσ a ,b + tσ a ,b + t 2σ b ,b + σ12
1 2
1 2
2 1
1 2
σ 2 + 2t 2σ a ,b + 2t 2σ 2 + σ12 σ 2 + 2t 2σ a ,b + 2t 2σ 2 + σ 22
1 1
2 2
a1
b1
a2
b2

(2.25)
.

The delta method could be used to obtain 95% confidence bounds for rM ( t ) at any
particular point in time.
Two observations can be made from equation (2.24). First, notice that when t = 0
the marginal correlation reduces to
rM ( t ) =

σ a ,a
1 2
σ 2 + σ12 σ 2 + σ 22
a1
a2

,

which is essentially the correlation between the two random intercepts. If fact, when the
error components are small, the closer the marginal correlation at t = 0 approximates the
correlation between the random intercepts. Also, as t increases rM ( t ) converges to rE
for the case with uncorrelated errors, and to
rM ( t ) =

σ a , a + σ12
1 2
σ 2 + σ12 σ 2 + σ 22
a1
a2
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,

for the case of correlated errors, which indicates that the absolute value of the marginal
correlation at t = 0 cannot be higher than the correlation between the random intercepts. It
may also be noted that as t increases the marginal correlation converges to the correlation
between the random slopes, while the variance-covariance parameters of the random
effects determine the shape of the marginal correlation function (Fieuws, et al. 2004).

2.6. Summary
The univariate normal random-effects model was first defined and methods for
estimation were discussed. The univariate definition was the extended to a more general
definition for the multivariate normal random-effects model. Univariate models can
essentially be joined together with a specific definition of the variance-covariance
structure for the random-effects.
Various structures of the G matrix are imposed to allow for different assumptions
of the random-effects. Both a complete independence approach and a shared-parameters
approach were considered. Finally, the methodology for determining the association of
the evolutions and the evolution of the association were discussed. Software packages
such as PROC MIXED and PROC GLIMMIX in SAS could be used to implement
multivariate longitudinal data analysis. In the following chapter, an application of the
multivariate mixed-model will be demonstrated using data from the Fels Longitudinal
Study.
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3

Data Analysis

3.1. Introduction
The methods for univariate and multivariate longitudinal analysis using the Fels
Longitudinal Study data are presented in this chapter. In sections 3.2 and 3.3 the Fels
study and the relevant data collected by the study are described. The methods used for
data management are detailed in section 3.4, while the results from the study are
discussed and conclusions drawn in section 3.5.

3.2. The Fels Longitudinal Study
Data from the Fels Longitudinal Study was chosen because it contains a large sample of
participants with serial measurements of the factors defining the metabolic syndrome
from the time of a participant’s birth until their death. The Fels Longitudinal Study is an
ongoing multidisciplinary serial study which began in 1929 as a means to investigate
child growth and development (Roche, 1992). To date, a myriad of data has been
collected on not just the original participants but also their children, grandchildren and
great grandchildren. The study does routine data collection multiple times per year for
participants in the study from birth until the age of twenty-one, then continues collecting
information every two years until death. Only a small percentage of participants
(approximately 8%) are lost to follow-up monitoring. The Fels Longitudinal Study
collects serial information on such areas as anthropometry, dual energy x-ray
absorptiometry, hydrodensitometry, residual volume, bioelectric impedance, total body
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water, grip strength and blood pressure, skeletal maturation, health history, menstruation,
smoking, alcohol, function, and physical activity. All procedures were approved by the
Wright State University institutional review board, and all participants gave written
consent in order to join the Fels Longitudinal Study. Recall, the specific measurements of
interest related to the metabolic syndrome, are waist circumference, blood pressure,
triglycerides, high density lipoprotein cholesterol (HDL-c), and serum glucose.

3.3. The Metabolic Syndrome Measurements

3.3.1

Blood Pressure

The measurements of a participant’s diastolic and systolic blood pressure (mm Hg) were
taken with a standard mercury sphygmomanometer every six months from age two
through age eighteen, and every two years from then on. Three measurements were taken
at each examination by a trained technician while participants were seated; the mean of
the last two measurements was recorded (Roche et al., 1992).

3.3.2

Waist Circumference

The measurement of an individual’s waist circumference (cm) was taken as part of the
anthropometric data collected by the Fels Longitudinal Study. The circumference of
one’s abdomen was taken using techniques similar to corresponding measurements in the
Anthropometric Standardization Reference Manual (Lohman et al., 1988). For the Fels
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data set, the measuring of waist circumference changed during the course of the study.
Specifically the study shifted from collecting waist circumference measurements made at
the iliac crest to collecting measurements made at the umbilicus, which is a more modern
method of waist circumference measurement. For the purposes of this research and the
proposed analysis, the difference in measurement location is not expected to have a
dramatic effect. For this analysis, if the iliac measurement for a participant is available it
will be used as the waist circumference measurement in the analysis, while the umbilicus
measurement will be used if the iliac is not available. All waist circumference
measurements recorded for the Fels Longitudinal Study were the average of two
measurements taken by independent observers. These measures were repeated if the two
observers differed by more than a preset error limit.

3.3.3

Blood Measures

The measurements of a participant’s serum glucose (mg/dL), triglyceride (mg/dL) and
high density lipoprotein cholesterol (HDL-c) (mg/dL) levels were observed using fasting
blood samples collected on participants via a venous blood draw. This information is not
collected until a participant is approximately eight years of age at the time of their visit.

3.3.4

Additional Measures

In addition to the measurements described above and the age at each visit, weight and
skeletal age at each visit and the sex of each participant were available. Weight was
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measured to 0.1 kg using a SECA brand scale. Skeletal age was assessed using a hand
radiograph of each participant through the age of eighteen. These radiographs were
scored using various established skeletal maturation assessment procedures, given that
skeletal maturation involves the changes in the bones as an individual becomes an adult.
Since hand-wrist x-rays were taken on most participants in the Fels study through the age
of eighteen, the “Fels method” was developed to determine skeletal ages using hand-wrist
x-rays through dual energy a-ray absoptiometry. The Fels method is based on ninetyeight indicators and thirteen measurements, of which only 25-30% may be used for a
given chronological age since there is a short range in which certain indicators actually
provide useful information (Roche et al., 1988). For the purposes of this analysis the
relative bone age will be used as a proxy for biological maturity. Relative bone age is
calculated by subtracting the chronological age from the skeletal bone age.

3.4. Data Management and Preparation
Several data management steps were taken to prepare the original data set for analysis.
This included preparing childhood data and determining which participants developed the
metabolic syndrome in adulthood. All data management was performed with SAS 9.2,
see Appendix section 6.1 and section 6.2.
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3.4.1

Childhood Subset

The outcome variables of interest for the analyses include the childhood (ages two
through eighteen) measures of systolic and diastolic blood pressure. While the other
factors of the metabolic syndrome (waist circumference, HDL-c, triglycerides, and
glucose) were not analyzed as outcome variables, this information was retained from
participant’s childhood visits for descriptive purposes and future considerations. The
independent childhood variables included sex, birth weight, and skeletal age. Skeletal age
is a time dependent covariate, while sex and birth weight are independent of age at the
time of visit. It should be noted that birth weight was not included in the original data set
as a variable; rather, a participant’s earliest weight measurement recorded (no more than
five days after birth) was used.
In organizing the data a subset was created (CHILD) which included multiple
rows per subject; one row per visit for ages two (inclusive) through nineteen (exclusive).
The columns consisted of the outcome measures of interest (systolic and diastolic blood
pressure, as well as waist circumference, triglycerides, HDL-c, and serum glucose), the
chronological age at which each measurement was collected, the participant’s skeletal
age at each visit, birth weight, and sex, as well as a unique participant identification
number.
The CHILD subset consisted of 1361 subjects with a total of 24745 visits. Each
participant was seen an average of approximately 18.18 times (standard deviation =
15.24, median = 17). The fewest number of visits for a single participant during
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childhood was one, while the highest number of childhood visits for a single participant
was ninety-five. The distribution of the number of childhood visits for the 1361
participants is shown in Figure 1.
Figure 1: Distribution of the Number of Childhood Visits
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Adulthood Subset

A second subset (ADULT) was created which contained the adulthood measurements of
participants, between the ages of thirty and fifty-five. This subset contained those risk
factor measurements specific to the metabolic syndrome for participants in adulthood
such that there were multiple rows per subject (one row per visit). Recall, the categorical
cut-points for the risk factors are: a systolic blood pressure that is more than 130mm Hg
44

or a diastolic blood pressure that is more than 85mm Hg, a waist circumference that is
greater than 102 cm for men and greater than 88 cm for women, a triglyceride count that
is greater than 150 mg/dL, an HDL-c that is less than 40 mg/dL for men and less than 50
mg/dL for women, and a fasting serum glucose that is greater than 100 mm/dL.
There were a total of 5165 visits from 1194 subjects in the ADULT subset with
4.3 visits on average (standard deviation = 5.46, median = 3) between the ages of thirty
and fifty-five. The minimum number of visits for a subject between the ages of thirty and
fifty-five was one while the maximum number of visits was fifty-eight. The distribution
of the number of adulthood visits for the 1194 participants is shown in Figure 2.

Figure 2: Distribution of the Number of Adulthood Visits
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Given the measurements for each participant in adulthood, the number of risk
factors each participant had at each adulthood visit was calculated. More specifically, it
was determined whether a participant had no risk factors, exactly one, two, three, four or
five risk factors at each visit in adulthood. In addition to the exact number of risk factors
at each visit, it was determined whether a participant had at least one, two, three, four, or
five risk factors at each visit in adulthood (for example, if a person had three risk factors,
they would be flagged as having ‘at least one risk factor’, ‘at least two risk factors’, and
‘at least three risk factors’).
These risk factor variables for the 1194 subjects in the ADULT subset were
merged with the 1361 subjects in the CHILD subset in order to create the dataset used for
analysis (FINAL). A participant was included in the FINAL dataset if, and only if, they
had measurements recorded in childhood (ages two through eighteen) and recorded in
adulthood (ages thirty through fifty-five). The total number of subjects across both
CHILD and ADULT subsets was 2035; however, 841 subjects were in the CHILD subset
but not in the ADULT subset, while 674 subjects were in the ADULT subset but not in
the CHILD subset. Thus, there were only 520 subjects in both the CHILD and ADULT
subsets, meaning the FINAL subset to be used for analysis contained 520 subjects. All
henceforth summaries are based on this sample of 520 individuals from the FINAL
subset.
The distribution of the number of participants who were never diagnosed with any
of the metabolic syndrome risk factors in adulthood and those who were diagnosed with
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at least one, two, three, four and five risk factors (at some point during adulthood) are
summarized in Table 2.

Table 2: Distribution of Adulthood Risks for the Metabolic Syndrome
Number of Risk Factors
None
At Least One
At Least Two
At Least Three
At Least Four
At Least Five

Count
67
399
258
153
82
21

Total
466
466
470
464
477
510

Percent
14.38%
85.62%
54.89%
32.97%
17.19%
4.12%

A participant was considered to have developed the metabolic syndrome in
adulthood if they developed three or more risk factors, simultaneously, for at least one
visit between the ages of thirty and fifty-five. The primary goal of this study is to
determine if the 153 participants who developed the metabolic syndrome (at least three
risk factors) differ from the sixty-seven participants who did not develop any of the
metabolic syndrome risk factors in adulthood, with respect to systolic and diastolic blood
pressure measures during childhood.

3.4.3

Further Considerations

Investigation of the response variables of interest during childhood yields a high degree
of missing data of those factors related to blood measures (triglycerides, HDL-c, and
glucose). Of the 14848 visits available from ages two through eighteen across the 520
participants, diastolic blood pressure was missing for 7802 visits (52.55%), systolic blood
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pressure was missing for 7787 visits (52.44%), waist circumference was missing for 2870
visits (19.33%), triglycerides was missing for 14247 visits (95.95%), HDL-c was missing
for 14250 visits (95.97%), and glucose was missing for 14756 visits (99.38%). It is
unclear why the missing data rate is so high for all of the measures, especially the
measures obtained from a venous blood sample. While the large degree of missing blood
measures could be attributed to these measures not commencing until age eight, rates
above 95% are still unusually high. Another reason for the missing data rates could be
attributed to visits spanning over more than one day. For example, a participant could be
seen over several days, with blood pressure recorded on day one, waist circumference on
day two, and blood taken on day three. This would result in the participants having three
visits, with data missing on each of these measures 67% of the time. Regardless of the
reason for missing data, it is difficult to consider including the childhood blood measures
(HDL-c, triglyceride, and glucose) for analysis in this study.

3.5. Results

3.5.1

Description of the Sample

There were 153 individuals (69.5%) in the Metabolic Syndrome (MetS) Group; that is,
the group of adults who were diagnosed with three or more of the metabolic syndrome
risk factors at least once between the ages of thirty and fifty-five. There were sixty-seven
(30.5%) individuals in the No Risk Factor (No MetS) Group; that is, the group of adults
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who were never diagnosed with any of the metabolic syndrome risk factors between the
ages of thirty and fifty-five. For this sample of 220 individuals, 112 (50.9%) were male,
while 108 (49.1%) were female. The mean birth weight was 3.29 kg (standard deviation
= 0.58). There were nineteen participants missing birth weight information; six were in
the No MetS Group and thirteen were in the MetS Group. The average age the
participants in the MetS Group were first determined to have at least three of the
metabolic syndrome risk factors in adulthood was 41.7 years (standard deviation = 7.58).
The following sections describe the results from the univariate and multivariate
models separately for male and female participants. Male subjects are considered in
section 3.5.2, with the univariate models being discussed first, followed by a multivariate
model section. Female subjects are considered in section 3.5.3, with the univariate
models being discussed first, followed by a multivariate model section. The chapter
concludes with a comparison section (3.5.4) that discusses the different models for male
and female participants.

3.5.2

Univariate and Multivariate Models for Male Subjects

3.5.2.1 Univariate Models
For the subset of 112 male participants a multivariate mixed-effects model was fit for the
two response variables, diastolic blood pressure (DBP) and systolic blood pressure
(SBP), assuming a complete independence variance-covariance structure as described in
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section 2.5.1.1. This model produces the same results as two separate univariate mixedeffects models, but allows for a single likelihood for the model parameters enabling direct
comparison with the correlated multivariate model fit in the subsequent section. This
model was fit allowing for a separate quartic age effect for each metabolic syndrome
group (MetS, No MetS), and adjusted for relative age and birth weight. Random
intercepts and (linear first order) slopes were fit for each participant to account for
within-subject correlations. The fixed-effects tests for the two response variables are
summarized in Table 3.

Table 3: Fixed-Effects Tests for Males (Univariate)
DBP
SBP
Effect
NDF DDF F p-value NDF DDF F
1 803 0.35 0.5544
1 714 5.77
Relative Age
1 77.1 0.06 0.8127
1 87.4 1.11
Birth Weight
1 1099 7.44 0.0065
1 1113 10.48
Age
1 1044 0.66 0.4157
1 1055 5.09
METS Group
1 1094 0.07 0.7908
1 1109 5.45
Age x MetS Group
2
1 1101 6.06 0.0140
1 1116 9.80
Age
2
1 1095 0.03 0.8627
1 1111 4.71
Age x MetS Group
3
1 1100 5.52 0.0190
1 1116 10.51
Age
1 1094 0.01 0.9096
1 1111 4.10
Age3 x MetS Group
4
1 1099 4.83 0.0281
1 1116 10.12
Age
4
1 1093 <0.01 0.9682
1 1109 3.61
Age x MetS Group
NDF, DDF = numerator, denominator degrees of freedom
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p-value
0.0165
0.2958
0.0012
0.0242
0.0197
0.0018
0.0303
0.0012
0.0431
0.0015
0.0577

Examining Table 3, there was evidence of a statistically significant quartic
relationship between age and both DBP (p-value = 0.0281) and SBP (p-value = 0.0015)
for males. However, this quartic relationship was not significantly different between the
two MetS Groups (MetS and No MetS) for either DBP (p-value = 0.9682) or SBP (pvalue = 0.0577). The differences in DBP and SBP between the metabolic syndrome
groups at each age for males are summarized in Table 4.
The univariate plots for DBP and SBP are summarized in Panels (a) and (b) of
Figure 3. From these plots notice that both DBP and SBP increased with age, with greater
increases associated with SBP than with DBP. In general, it also appears that those who
developed at least three metabolic syndrome risk factors in adulthood had higher blood
pressure measures during childhood than those who did not develop any metabolic
syndrome risk factors in adulthood.
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Table 4: Male’s LS Means Differences (Univariate)

Age
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

DBP (MetS-No MetS)
SBP (MetS-No MetS)
Difference SE p-value
95% CI
Difference SE p-value
95% CI
10.250 6.466 0.1135 (-2.451, 22.952)
-11.010 6.384 0.0827 (-23.640, 1.441)
9.116 4.222 0.0320 (0.793, 17.438)
-3.791 4.171 0.3644 (-12.011, 4.430)
8.248 3.259 0.0127 (1.794, 14.702)
0.792 3.221 0.8062 (-5.583, 7.168)
7.598 2.887 0.0098 (1.875, 13.322)
3.322 2.852 0.2465 (-2.327, 8.971)
7.120 2.630 0.0079 (1.904, 12.335)
4.388 2.592 0.0933 (-0.748, 9.524)
6.767 2.373 0.0053 (2.058, 11.476)
4.495 2.328 0.0562 (-0.120, 9.110)
6.498 2.157 0.0033 (2.214, 10.782)
4.064 2.099 0.0556 (-0.100, 8.228)
6.270 2.024 0.0026 (2.250, 10.289)
3.433 1.947 0.0806 (-0.426, 7.293)
6.043 1.958 0.0026 (2.158, 9.929)
2.856 1.855 0.1265 (-0.820, 6.532)
5.780 1.914 0.0032 (1.984, 9.576)
2.502 1.780 0.1625 (-1.023, 6.027)
5.445 1.870 0.0045 (1.733, 9.157)
2.458 1.610 0.1510 (-0.909, 5.825)
5.002 1.855 0.0083 (1.319, 8.686)
2.725 1.642 0.1000 (-0.531, 5.981)
4.421 1.904 0.0225 (0.638, 8.203)
3.223 1.653 0.0539 (-0.055, 6.500)
3.669 2.010 0.0712 (-0.324, 7.661)
3.786 1.727 0.0304 (0.364, 7.208)
2.718 2.112 0.2017 (-1.481, 6.916)
4.165 1.796 0.0224 (0.603, 7.727)
1.540 2.228 0.4915 (-2.894, 5.974)
4.028 1.881 0.0349 (0.293, 7.761)
0.110 2.736 0.9680 (-5.302, 5.522)
2.955 2.406 0.2211 (-1.794, 7.704)
Using an α = .05 decision rule, there are significant differences between the MetS

Group and the No MetS Group at ages three through fourteen (p-values ≤ 0.0320) for
DBP, and at ages fifteen through seventeen (p-values < 0.0350) for SBP. However, when
using a more conservative Bonferroni adjustment for multiple comparisons of

α = .05 17 = .0029 the only statistically significant differences that remain were at ages
nine and ten (both p-values = .0026) for DBP.
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Figure 3: DBP and SBP Plots for Male Subjects (Univariate and Multivariate Models)
SBP Males, 4th Order Full Model, Univariate
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There was also evidence that relative age had a significant effect on SBP (p-value
= 0.0165), but not on DBP (p-value = 0.5544). Amongst males, a one year increase in
relative age (i.e. physical maturity) was significantly associated with a 0.931 increase (SE
= 0.388; 95% CI = [0.170, 1.692]) in SBP. A one year increase in relative age was
associated with a nominal decrease of 0.240 (SE = 0.406; 95% CI = [-1.036, 0.556]) in
DBP. There was not evidence of a significant relationship between birth weight and
either DBP (p-value = 0.8127) or SBP (p-value = 0.2958). For males, a one kg increase in
birth weight was associated with a nominal decrease of 1.186 (SE = 1.128; 95% CI = [3.428, 1.055]) in SBP, and a nominal decrease of 0.302 (SE = 1.268; 95% CI = [-2827,
2.224]) in DBP.
Now that the fixed effects have been considered for the male univariate models,
the random effects (intercepts and slopes) will be investigated. The estimated variancecovariance matrix, G, and the estimated G correlation matrix for both the DBP and the
SBP response variables may be seen below in Table 5 and Table 6, respectively.

Table 5: Estimated G Variance-Covariance Matrix for Males (Univariate)

DBP
SBP

DBP
SBP
Intercept Slope Intercept Slope
Intercept 173.240 -10.441
-10.441 0.845
Slope
169.550 -9.962
Intercept
-9.962 0.722
Slope
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Table 6: Estimated G Correlation Matrix for Males (Univariate)

DBP
SBP

DBP
SBP
Intercept Slope Intercept Slope
1.000 -0.863
Intercept
-0.863
1.000
Slope
1.000 -0.901
Intercept
-0.901 1.000
Slope

From Table 5, it may be seen that variability in the random intercepts and slopes
is relatively similar for both DBP and SBP, though the variability for DBP is slightly
higher. The same may be said of the covariance between the intercepts and slopes for
SBP and DBP; while both are similar, DBP appears to be more extreme. Also, while not
only being similar, the covariance’s for both DBP and SBP are negative, which is
indicative of a negative correlation, as seen in the G correlation matrix in Table 6. This
negative correlation indicates that participants with lower SBP and DBP intercepts (blood
pressure at “age = 0”) have higher increases in blood pressure over childhood (slopes),
while participants with higher SBP and DBP intercepts have lower increases in blood
pressure over time.

3.5.2.2 Multivariate Model
For the subset of 112 male participants, a multivariate mixed-effects model was
fit with for the two response variables, DBP and SBP, assuming an unstructured
variance-covariance structure as discussed in section 2.5. This model is the same as the
55

univariate model discussed in the previous section, except the sets of random intercepts
and slopes for each response are now correlated rather than independent. This
multivariate model was fit allowing for a separate quartic age effect for each metabolic
syndrome group (MetS, No MetS), and adjusted for relative age and birth weight.
Random intercepts and (linear first order) slopes were fit for each participant to account
for within-subject correlations. The fixed-effects tests for the two response variables are
summarized in Table 7.
The multivariate plots for DBP and SBP are summarized in Panels (c) and (d) of
Figure 3. From these plots notice that both DBP and SBP increased with age, with greater
increases associated with SBP than with DBP. In general, it also appears that those who
developed at least three metabolic syndrome risk factors in adulthood had higher blood
pressure measures during childhood than those who did not develop any metabolic
syndrome risk factors in adulthood.
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Table 7: Fixed-Effects Tests for Males (Multivariate)
Multivariate Males
Effect
NDF DDF F p-value
1 810 4.97 0.0261
Response
1 1209 0.13 0.7144
Relative Age
1 81.8 0.61 0.4381
Birth Weight
1 399 8.59 0.0036
Relative Age x Response
1 76.5 0.82 0.3693
Birth Weight x Response
1 2113 18.15 <.0001
Age
1 1749 1.21 0.2720
METS Group
1 2107 2.06 0.1512
Age x MetS group
1 1319 0.96 0.3274
Age x Response
1 989 3.29 0.0701
Response x MetS Group
1 1303 2.38 0.1228
Age*Response x MetS Group
2
1 2128 16.03 <.0001
Age
2
1 1462 1.00 0.3178
Age x Response
2
1 2120 1.76 0.1851
Age x MetS Group
2
1 1441 2.07 0.1507
Age x Response x MetS Group
3
1 2131 16.06 <.0001
Age
3
1 1579 1.19 0.2753
Age x Response
3
1 2123 1.53 0.2161
Age x MetS Group
3
1 1557 1.82 0.1771
Age x Response x MetS group
4
1 1721 14.29 0.0002
Age
4
1 1665 2.63 0.1053
Age x Response
4
1 1674 2.29 0.1302
Age x MetS Group
4
1 1663 1.57 0.2111
Age x Response x MetS Group
NDF, DDF = numerator, denominator degrees of freedom

As with the two univariate models, the multivariate model showed evidence of a
significant quartic relationship between age and both responses, DBP (p-value = 0.0425)
and SBP (p-value = 0.0003). Furthermore, there was not evidence of a significant
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difference between the two MetS Groups for either DBP (p-value = 0.9987) or SBP (pvalue = 0.0835). The differences in DBP and SBP between the metabolic syndrome
groups at each age for males are summarized in Table 8.
Using an α = .05 decision rule, there were significant differences between the
MetS Group and the No MetS Group at ages four through fourteen (p-values ≤ 0.0409)
for DBP, and at ages fourteen through seventeen (p-values ≤ 0.0382) for SBP. However,
when using a more conservative Bonferroni adjustment for multiple comparisons of

α = .05 17 = 0.0029, the only statistically significant differences that remain were at ages
nine and ten (both p-values ≤ 0.0023) for DBP.
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Table 8: Male’s LS Means Differences (Multivariate)
DBP (MetS-No MetS)
SBP (MetS-No MetS)
AGE Difference SE p-value
95% CI
Difference SE p-value
95% CI
6.477 6.299 0.3044 (-5.900, 18.854)
-9.830 6.281 0.1183 (-22.170, 2.513)
2
6.481 4.082 0.1140 (-1.570, 14.532)
-3.290 4.116 0.4257 (-11.400, 4.828)
3
6.497 3.140 0.0409 (0.275, 12.719)
0.833 3.199 0.7950 (-5.499, 7.164)
4
6.510 2.789 0.0216 (0.977, 12.043)
3.128 2.850 0.2748 (-2.519, 8.775)
5
6.508 2.553 0.0123 (1.443, 11.572)
4.126 2.607 0.1163 (-1.040, 9.292)
6
6.476 2.315 0.0062 (1.881, 11.070)
4.277 2.358 0.0725 (-0.398, 8.952)
7
6.401 2.115 0.0032 (2.200, 10.602)
3.955 2.141 0.0676 (-0.292, 8.201)
8
6.269 1.995 0.0022 (2.308, 10.231)
3.458 1.994 0.0859 (-0.497, 7.412)
9
6.068 1.938 0.0023 (2.222, 9.913)
3.011 1.903 0.1165 (-0.760, 6.782)
10
5.783 1.902 0.0030 (2.012, 9.554)
2.762 1.826 0.1331 (-0.855, 6.378)
11
5.401 1.866 0.0047 (1.698, 9.104)
2.782 1.743 0.1134 (-0.672, 6.236)
12
4.909 1.859 0.0097 (1.217, 8.602)
3.070 1.683 0.0711 (-0.269, 6.408)
13
4.294 1.917 0.0275 (0.487, 8.102)
3.546 1.689 0.0382 (0.197, 6.896)
14
3.543 2.027 0.0838 (-0.483, 7.569)
4.058 1.754 0.0226 (0.581, 7.534)
15
2.643 2.131 0.2182 (-1.592, 6.878)
4.375 1.813 0.0176 (0.779, 7.972)
16
1.580 2.246 0.4838 (-2.890, 6.051)
4.194 1.888 0.0287 (0.446, 7.943)
17
0.343 2.750 0.9010 (-5.098, 5.783)
3.134 2.403 0.1939 (-1.608, 7.876)
18

There was evidence that relative age had a significant effect on SBP (p-value =
0.0342), but not on DBP (p-value = 0.1401). Amongst males, a one year increase in
relative age (i.e. physical maturity) was significantly associated with a 0.794 increase (SE
= 0.374, 95% CI = [0.059, 1.528] in SBP. A one year increase in relative age was
associated with a nominal decrease of 0.573 (SE = 0.388; 95% CI = [-1.334, 0.189]) in
DBP. There was not evidence of a significant relationship between birth weight and
either DBP (p-value = 0.7677) or SBP (p-value = 0.2610). For males, a one kg increase in
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birth weight was associated with a nominal decrease of 0.366 (SE = 1.235; 95% CI = [2.825, 2.093]) in DBP, and a nominal decrease of 1.314 (SE = 1.161; 95% CI = [-3.623,
0.995]) in SBP.
Now that the fixed effects have been considered for the male multivariate model,
the random effects (intercepts and slopes) will be investigated. For the male multivariate
model the estimated variance-covariance matrix, G, and the estimated G correlation
matrix for both the DBP and the SBP response variables may be seen in Table 9 and
Table 10, respectively.

Table 9: Estimated G Variance-Covariance Matrix for Males (Multivariate)

DBP
SBP

DBP
SBP
Intercept Slope Intercept Slope
Intercept 162.010 -9.6903 136.180 -7.424
-9.6903
0.800
-7.199 0.469
Slope
136.18 -7.199 171.930 -9.718
Intercept
-7.4235
0.469
-9.718 0.687
Slope

Table 10: Estimated G Correlation Matrix for Males (Multivariate)

DBP
SBP

DBP
SBP
Intercept Slope Intercept Slope
1.000
-0.851
0.816 -0.704
Intercept
-0.851
1.000
-0.614 0.633
Slope
0.816
-0.614
1.000 -0.894
Intercept
-0.704
0.633
-0.894 1.000
Slope
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From the random effects, it may be seen that variability is relatively similar for
both DBP and SBP, though the variability for DBP is slightly higher. The same may be
said of the covariance for SBP and DBP, while both are similar, DBP appears to be more
extreme. Also, while not only being similar, the covariance’s for both DBP and SBP are
negative, which is indicative of a negative correlation, which is seen in the G correlation
matrix.
With the multivariate mixed-effects model is possible to investigate how the
evolution of DBP is associated with the evolution of SBP, the association of the
evolutions (AOE). It is also possible to determine how the association between DBP and
SBP evolves over time, the evolution of the association (EOA).
The AOE can be determined by using equation (2.23) from section 2.5.2 or by
reading the correlation between the two slopes directly from the estimated G correlation
matrix (Table 10). Here the AOE between the random slope for DBP and the random
slope for SBP is 0.633.
The EOA can be determined, and then visualized, using the marginal correlation
between DBP and SBP, equation (2.25) from section 2.5.3. To visualize this, the implied
correlation has been calculated and plotted over time using the marginal correlation
between both frequencies in Figure 4. Notice that the association is strongest at age two
at around 0.6, and this association decreases over time, leveling out at approximately 0.2
between fourteen and sixteen years of age.
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Figure 4: Evolution of the Associations (Males)
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3.5.3

Univariate and Multivariate Models for Female Subjects

3.5.3.1 Univariate Models
For the subset of 108 female participants a multivariate mixed-effects model was fit for
the two response variables, diastolic blood pressure (DBP) and systolic blood pressure
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(SBP), assuming a complete independence variance-covariance structure as described in
section 2.5.1.1. This model produces the same results as two separate univariate mixedeffects models, but allows for a single likelihood for the model parameters enabling direct
comparison with the correlated multivariate model fit in the subsequent section. This
model was fit allowing for a separate quadratic age effect for each metabolic syndrome
group (MetS, No MetS), and adjusted for relative age and birth weight. Random
intercepts and (linear first order) slopes were fit for each participant to account for
within-subject correlations. The fixed-effects tests for the two response variables are
summarized in

Table 11.

Table 11: Fixed-Effects Tests for Females (Univariate)
DBP Females
SBP Females
Effect
NDF DDF F p-value NDF DDF F
p-value
1 809 1.60 0.2065
1
826 3.03 0.0821
Relative Age
1 74 1.80 0.1843
1 77.7 0.30 0.5885
Birth Weight
1 713 13.89 0.0002
1
732 29.38 <.0001
Age
1 322 0.26 0.6093
1
326 0.05 0.8151
MetS Group
1 706 3.17 0.0757
1
725 0.19 0.6661
Age x MetS Group
2
1 855 6.12 0.0136
1
881 11.02 0.0009
Age
2
1 852 4.71 0.0303
1
877 0.19 0.6599
Age x MetS Group
NDF, DDF = numerator, denominator degrees of freedom
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The univariate plots for DBP and SBP are shown in Panels (a) and (b) of Figure 5.
From these plots, notice that both DBP and SBP increase with age, with greater increases
associated with SBP than with DBP. In general, it also appears that those who develop at
least three metabolic syndrome risk factors in adulthood had higher blood pressure
measures during childhood than those who did not develop any metabolic syndrome risk
factors in adulthood.
Statistically, there was evidence of a significant quadratic relationship between
age and both DBP (p-value = 0.0136) and SBP (p-value = 0.0009) for females. This
quadratic relationship was significantly different between the two MetS Groups (MetS
and No MetS) for DBP (p-value = 0.0303) but not SBP (p-value = 0.6599). The
differences in DBP and SBP between the metabolic syndrome groups at each age for
females are summarized in Table 12.
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Table 12: Female’s LS Means Differences (Univariate)

Age
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

DBP (MetS-No MetS)
SBP (MetS-No MetS)
Difference SE p-value
95% CI
Difference SE p-value
95% CI
-0.040 4.501 0.9934 (-8.906, 8.831)
2.171 4.462 0.6271 (-6.620, 10.960)
1.263 3.812 0.7407 (-6.255, 8.782)
2.496 3.783 0.5102 (-4.960, 9.956)
2.395 3.215 0.4574 (-3.954, 8.744)
2.788 3.19 0.3835 (-3.510, 9.087)
3.358 2.712 0.2179 (-2.008, 8.723)
3.046 2.686 0.2589 (-2.270, 8.360)
4.152 2.306 0.0746 (-0.420, 8.724)
3.272 2.274 0.1531 (-1.240, 7.778)
4.778 1.998 0.0187 (0.812, 8.744)
3.464 1.954 0.0795 (-0.410, 7.342)
5.235 1.779 0.0041 (1.700, 8.770)
3.623 1.722 0.0382
(0.202, 7.044)
5.524 1.637 0.0011 (2.273, 8.775)
3.748 1.568 0.0189
(0.634, 6.862)
5.644 1.548 0.0004 (2.570, 8.717)
3.841 1.474 0.0106
(0.915, 6.766)
5.595 1.493 0.0003 (2.633, 8.557)
3.900 1.422 0.0072
(1.079, 6.721)
5.378 1.454 0.0004 (2.493, 8.264)
3.926 1.397 0.0060
(1.154, 6.698)
4.993 1.427 0.0007 (2.160, 7.825)
3.918 1.394 0.0060
(1.150, 6.687)
4.438 1.416 0.0024 (1.623, 7.253)
3.878 1.419 0.0076
(1.058, 6.698)
3.715 1.439 0.0118 (0.849, 6.581)
3.804 1.486 0.0124
(0.847, 6.761)
2.824 1.525 0.068 (-0.214, 5.862)
3.697 1.616 0.0248
(0.480, 6.914)
1.764 1.699 0.3023 (-1.616, 5.144)
3.557 1.828 0.0549 (-0.080, 7.191)
0.535 1.979 0.7875 (-3.391, 4.461)
3.384 2.132 0.1157 (-0.850, 7.613)
Using an α = .05 decision rule, there were significant differences between the

MetS Group and the No MetS Group at ages seven through fifteen (p-values ≤ 0.0187)
for DBP, and at ages eight through sixteen (p-values ≤ 0.0382) for SBP. However, when
using a more conservative Bonferroni adjustment for multiple comparisons of

α = .05 17 = 0.0029 the only statistically significant differences that remain were at ages
nine through fourteen (p-values ≤ 0.0024) for DBP.

65

Figure 5: DBP and SBP Plots for Female Subjects (Univariate and Multivariate Models)
DBP Females, 2nd Order Full Model, Univariate
Adjusting for Relative Age and Birth Weight (a)

SBP Females, 2nd Order Full Model, Univariate
Adjusting for Relative Age and Birth Weight (b)
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DBP Females, 2nd Order Full Model, Multivariate
Adjusting for Relative Age and Birth Weight (c)

SBP Females, 2nd Order Full Model, Multivariate
Adjusting for Relative Age and Birth Weight (d)
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There was not evidence that relative age had a significant effect on DBP (p-value
= 0.2065) or on SBP (p-value = 0.0821). For females, a one year increase in relative age
was associated with a nominal increase of 0.462 (SE = 0.365; 95% CI = [-0.255, 1.179])
in DBP and a nominal increase of 0.623 (SE = 0.358; 95% CI = [-0.079, 1.324]) in SBP.
There was not evidence that birth weight had a significant effect on DBP (p-value =
0.1843) or SBP (p-value =0.5885). For females, a one kg increase in birth weight was
associated with a nominal increase of 1.679 (SE = 1.253; 95% CI = [-0.818, 4.175]) in
DBP and a nominal increase of 0.664 (SE = 1.222; 95% CI = [-1.77, 3.098]) in SBP.
Now that the fixed effects have been considered for the female univariate models,
the random effects (intercepts and slopes) will be investigated. For the female univariate
models, the estimated variance-covariance matrix, G, and the estimated G correlation
matrix for both the DBP and the SBP response variables may be seen in Table 13 and
Table 14, respectively.

Table 13: Estimated G Variance-Covariance Matrix for Females (Univariate)

DBP
SBP

DBP
SBP
Intercept Slope Intercept Slope
Intercept 138.910 -7.605
-7.605 0.530
Slope
153.230 -9.626
Intercept
-9.626 0.747
Slope
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Table 14: Estimated G Correlation Matrix for Females (Univariate)

DBP
SBP

DBP
SBP
Intercept Slope Intercept Slope
1.000 -0.886
Intercept
-0.886
1.000
Slope
1.000 -0.899
Intercept
-0.899 1.000
Slope

From Table 13, it may be seen that variability in the random intercepts and slopes
is relatively similar for both DBP and SBP, though the variability for SBP is slightly
higher (recall, this is the opposite of what was seen among the male participants). The
same may be said of the covariance between the random intercepts and slopes for SBP
and DBP, while both are similar, SBP appears to be slightly more extreme. Also, while
not only being similar, the covariance’s for both DBP and SBP are negative, which is
indicative of a negative correlation, as seen in the G correlation matrix.

3.5.3.2 Multivariate Model
For the subset of 108 female participants, a multivariate mixed-effects model was fit with
for the two response variables, DBP and SBP, assuming an unstructured variancecovariance structure as discussed in section 2.5. This model is the same as the univariate
model discussed in the previous section, except the sets of random intercepts and slopes
for each response are now correlated rather than independent. This multivariate model
was fit allowing for a separate quadratic age effect for each metabolic syndrome group
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(MetS, No MetS), and adjusted for relative age and birth weight. Random intercepts and
(linear first order) slopes were fit for each participant to account for within-subject
correlations. The fixed-effects tests for the two response variables are summarized in
Table 15.

Table 15: Fixed-Effects Tests for Females (Multivariate)
Effect
NDF DDF F p-value
1 209 49.87 <.0001
Response
1 1478 1.35 0.2448
Relative Age
1 72 0.99 0.3235
Birth Weight
1 423 2.06 0.1515
Relative Age x Response
1 92.4 0.49 0.4869
Birth Weight x Response
1 1158 43.16 <.0001
Age
1 336 0.20 0.6523
MetS Group
1 1147 3.19 0.0743
Age x MetS group
1 370 1.75 0.1863
Age x Response
1 200 0.47 0.4915
Response x MetS Group
1 362 1.51 0.2202
Age*Response x MetS Group
2
1 1638 19.73 <.0001
Age
2
1 506 0.48 0.4874
Age x Response
2
1 1630 4.36 0.0370
Age x MetS Group
2
1 496 2.48 0.1158
Age x Response x MetS Group
NDF, DDF = numerator, denominator degrees of freedom

The multivariate plots for DBP and SBP are shown in Panels (c) and (d) of Figure
5. From these plots, notice that both DBP and SBP increases with age, with greater
increases associated with SBP than with DBP. In general, it also appears that those who
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developed at least three metabolic syndrome risk factors in adulthood had higher blood
pressure measures during childhood than those who did not develop any metabolic
syndrome risk factors in adulthood.
As with the two univariate models, the multivariate model indicated evidence of a
significant quadratic relationship between age and both responses, DBP (p-value =
0.0030) and SBP (p-value < 0.0001). Furthermore, there was evidence of a significant
difference between the two MetS Groups for DBP (p-value = 0.0099), however, there
was not evidence of a significant difference between the two MetS Groups for SBP (pvalue = 0.5229). The differences in DBP and SBP between the metabolic syndrome
groups at each age for females are summarized in Table 16.
Using an α = .05 decision rule, there were significant differences between the
MetS Group and the No MetS Group at ages seven through fifteen (p-values ≤ 0.0210)
for DBP, and at ages nine through seventeen (p-values ≤ 0.0479) for SBP. However,
when using a more conservative Bonferroni adjustment for multiple comparisons of

α = .05 17 = 0.0029 the only statistically significant differences that remain were at ages
nine through thirteen (p-values ≤ 0.0012) for DBP.
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Table 16: Female’s LS Means Differences (Multivariate)

Age
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

DBP (MetS-No MetS)
SBP (MetS-No MetS)
Difference SE p-value
95% CI
Difference SE p-value
95% CI
-0.838 4.280 0.8450 (-9.274, 7.599)
1.080 4.313 0.8024 (-7.417, 9.577)
0.643 3.644 0.8602 (-6.548, 7.833)
1.578 3.675 0.6681 (-5.671, 8.827)
1.934 3.095 0.5331 (-4.182, 8.050)
2.030 3.120 0.5161 (-4.131, 8.192)
3.035 2.636 0.2518 (-2.182, 8.253)
2.437 2.648 0.3592 (-2.802, 7.675)
3.947 2.268 0.0847 (-0.550, 8.444)
2.797 2.262 0.2188 (-1.684, 7.278)
4.67 1.989 0.0210 (0.721, 8.619)
3.112 1.960 0.1155 (-0.777, 7.000)
5.203 1.792 0.0046 (1.644, 8.761)
3.381 1.738 0.0548 (-0.071, 6.832)
5.546 1.661 0.0012 (2.248, 8.844)
3.604 1.587 0.0254
(0.453, 6.754)
5.700 1.577 0.0005 (2.570, 8.830)
3.781 1.491 0.0128
(0.822, 6.740)
5.665 1.522 0.0003 (2.644, 8.685)
3.912 1.435 0.0076
(1.064 6.760)
5.440 1.483 0.0004 (2.495, 8.384)
3.997 1.409 0.0055
(1.202, 6.793)
5.025 1.456 0.0009 (2.132, 7.918)
4.037 1.407 0.0051
(1.242, 6.832)
4.421 1.446 0.0030 (1.543, 7.299)
4.031 1.436 0.0063
(1.174, 6.888)
3.628 1.471 0.0160 (0.696, 6.559)
3.979 1.510 0.0102
(0.971, 6.987)
2.645 1.554 0.0932 (-0.454, 5.744)
3.881 1.646 0.0210
(0.601, 7.161)
1.472 1.720 0.3947 (-1.952, 4.897)
3.737 1.860 0.0479
(0.036, 7.439)
0.111 1.986 0.9557 (-3.830, 4.051)
3.548 2.162 0.1039 (-0.742, 7.838)

There was not evidence that relative age had a significant effect on either DBP (pvalue = 0.944), or on SBP (p-value = 0.0708). Amongst females, a one year increase in
relative age was associated with a nominal increase of 0.024 (SE = 0.344, 95% CI = [0.651, 0.699] in DBP and a nominal increase of 0.611 (SE = 0.338, 95% CI = [-0.052,
1.274]) in SBP. There was also not evidence of a significant relationship between birth
weight and either DBP (p-value = 0.2442) or SBP (p-value = 0.5189). For females, a one
kg increase in birth weight was associated with a nominal increase of 1.511 (SE = 1.287;
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95% CI = [-1.054, 4.075]) in DBP, and a nominal increase of 0.8137 (SE = 1.256; 95%
CI = [-1.687, 3.315]) in SBP.
Now that the fixed effects have been considered for the female Multivariate
model, the random-effects (intercept and slopes) will be investigated. For the female
multivariate model the estimated variance-covariance matrix, G, and the estimated G
correlation matrix for both the DBP and the SBP response variables may be seen in Table
17 and Table 18.

Table 17: Estimated G Variance-Covariance Matrix for Females (Multivariate)

DBP
SBP

DBP
SBP
Intercept Slope Intercept Slope
Intercept 139.800 -7.453 142.500 -9.157
-7.453
0.518
-7.777 0.603
Slope
Intercept 142.500 -7.777 165.830 -10.510
-9.157
0.603 -10.510 0.817
Slope

Table 18: Estimated G Correlation Matrix for Females (Multivariate)

DBP
SBP

DBP
SBP
Intercept Slope Intercept Slope
1.000 -0.876
0.936 -0.857
Intercept
-0.876 1.000
-0.839 0.928
Slope
0.936 -0.839
1.000 -0.903
Intercept
-0.857 0.928
-0.903 1.000
Slope

From Table 16, it may be seen that variability is relatively similar for both DBP
and SBP, though the variability for SBP is slightly higher. The same may be said of the
72

covariance for DBP and SBP, while both are similar, SBP appears to be slightly more
extreme. Also, while not only being similar, the covariance’s for both DBP and SBP are
negative, which is indicative of a negative correlation, as seen in the G correlation
matrix.
With the multivariate mixed-effects model is possible to investigate how the
evolution of DBP is associated with the evolution of SBP, the association of the
evolutions (AOE). It is also possible to determine how the association between DBP and
SBP evolves over time, the evolution of the association (EOA).
The AOE can be determined by using equation (2.23) from section 2.5.2 or by
reading the correlation between the two slopes directly from the estimated G correlation
matrix (Table 18). Here the AOE between the random slope for DBP and the random
slope for SBP is 0.928. The association in the evolutions of DBP and SBP is much higher
than that seen with males (recall, for the male participants AOE = 0.663).
The EOA can be determined, and then visualized, using the marginal correlation
between DBP and SBP, equation (2.25) from section 2.5.3. To visualize this, the implied
correlation has been calculated and plotted over time using the marginal correlation
between both frequencies in Figure 6. Notice, that at its strongest the correlation is just
less than 0.7, at age two, and this association decreases over time through age fourteen
where it bottoms out at approximately 0.3. At age fourteen the correlation begins to
increase through age eighteen, nearing an association of approximately 0.4. For females,
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this increase in the AOE in the later ages of childhood is far more extreme than that seen
with males.

Figure 6: Associations of the Evolution (Females)
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3.5.4

Comparisons

Now that both univariate and multivariate mixed-effects models have been considered
for male and female participants, some time will be taken to compare both types of
mixed-models for each sex. For the male participants, the estimated values for both the
variance-covariance G matrix (Table 5) and the correlation G matrix (Table 6) have been
combined for comparison purposes in Table 19, for both the univariate models and the
multivariate model. When comparing the results from the independent setting to the
results from the multivariate setting there are several points of interest. The -2 loglikelihood value corresponding to the two univariate models for males (fit as a joint
model with appropriate covariance terMetS equal to zero) was equal to 17000.1. The -2
log-likelihood value for the multivariate model was 16962.4. A likelihood ratio test
indicated that the multivariate model provided a significantly better fit than the two
univariate models ( χ 2 = 37.7 , df=4, p-value <0.0001). With regards to Akaike’s
information criterion (AIC), the multivariate model (AIC = 16962.4) is also indicated as a
better fit than the univariate model (AIC = 17016.1) (since a smaller AIC value indicates
a better fit). Notice how the multivariate model seems to decrease the variability in the
random effects, this may be seen in Table 19, or by recalling Table 5 and Table 9. Taking
into account the SE’s for the variance and covariance estimates, the multivariate model in
general allowed for more accurate prediction (smaller errors) of the variability in the
random effects, though just slightly.
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Table 19: REML Estimates for the Covariance and Correlation Parameters in the
Univariate and Multivariate Models for the Male Participants

-2 Res ll
AIC

σ2

a1
σa a
1 2
σ2
a2
σa b
11

σa b
21
σ2

b1
σa b
12

σa b
2 2
σb b
12
σ2
b2

Covariance Estimates
Correlation Estimates
Univariate
Multivariate Univariate
Multivariate
17000.1
16938.4
17000.1
16938.4
17016.1
16962.4
17016.1
16962.4
173.240 (37.131) 162.010 (35.439)

1.000

1.000

- 136.180 (29.048)

-

0.816

169.550 (35.441) 171.930 (34.975)

1.000

1.000

-10.441 (2.062)

-9.690 (2.496)

-0.086

-0.851

-

-7.199 (2.029)

-

-0.614

0.845 (0.203)

0.800 (0.196)

1.000

1.000

-

-7.424 (1.932)

-

-0.704

-9.962 (2.404)

-9.718 (2.305)

-0.901

-0.894

-

0.468 (0.137)

-

0.633

0.722 (0.176)

0.687 (0.165)

1.000

1.000

σ12

56.322 (2.529)

56.509 (2.546) 56.322 (2.529) 56.509 (2.546)

σ 22

55.289 (2.460)

55.330 (2.457) 55.289 (2.460) 55.330 (2.457)

(-2 Res ll = log-likelihood, AIC = Akaike’s information criterion.)

Comparing the fixed effects for the univariate and multivariate mixed-models for
the male subjects, some interesting things may be considered. First, and foremost, there
is the question of whether the different models reached the same bottom-line conclusion.
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Recall, that for the univariate model (Table 4), significant differences were found
between the two MetS groups at ages three through fourteen, for DBP, and fifteen
through seventeen, for SBP. Compare this to the multivariate model (Table 8), where
significant differences were found between the two MetS groups at ages four through
fourteen, for DBP, and fourteen through seventeen, for SBP. Essentially the same
conclusion was drawn for both models. Moreover, both the univariate and multivariate
models found that only ages nine and ten, for DBP, were significant when using a more
conservative Bonferroni correction.
What is even more telling, when comparing the two models’ LS means
differences (i.e. comparing Table 4 and Table 8), was the precision of these differences.
For each age, not only were the estimates for the differences slightly smaller for the
multivariate model, the SE’s were also slightly smaller, when compared to the univariate
model. The SE’s provided further evidence that, when applicable, fitting a joint
multivariate mixed-effects model is superior to fitting multiple univariate models.
Comparing the covariates between the two types of models will yield further
information of interest. Recall, from section 3.5.2, that both the univariate and
multivariate models found a significant relationship between relative age and SBP. Both
were positively associated with SBP (slopes of 0.794 compared to 0.931), however, the
SE (0.374 compared to 0.388) was smaller for the multivariate model, hence the 95% CI
was also tighter for the multivariate model. Both models also concluded a nominal
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decrease with regards to relative age for DBP, and with regards to birth weight for both
DBP and SBP, see Table 20.

Table 20: Covariate Comparison for Male Subjects
Slope (SE)
Relative Age
Univariate
Multivariate
Birth Weight
Univariate
Multivariate

DBP
95% CI

p-value

Slope (SE)

SBP
95% CI

p-value

-0.240 (0.406)
-0.573 (0.388)

(-1.036, 0.556)
(-1.334, 0.189)

0.5544
0.1401

0.931 (0.388)
0.794 (0.374)

(0.170, 1.692)
(0.059, 1.528)

0.0165
0.0342

-0.302 (1.268)
-0.366 (1.235)

(-2.827, 2.224)
(-2.825, 2.093)

0.8127 -1.186 (1.128)
0.7677 -1.314 (1.161)

(-3.428, 1.055)
(-3.623, 0.995)

0.2958
0.2610

For the female participants, the estimated values for both the variance-covariance
G matrix (Table 13) and the correlation G matrix (Table 10Table 14) have been
combined for comparison purposes in Table 21, for both the univariate models and the
multivariate models. When comparing the results from the independent setting to the
results from the multivariate setting there are several points of interest. The -2 loglikelihood value corresponding to the two univariate models (fit as a joint model with
appropriate covariance terMetS equal to zero) was equal to 14396.4. The -2 loglikelihood value for the multivariate model was 14297.4. A likelihood ratio test indicated
that the multivariate model provided a significantly better fit than the two univariate
models ( χ 2 = 99 , df=4, p-value <0.0001). With regards to Akaike’s information criterion
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(AIC) the multivariate model (AIC = 16962.4) is also a better fit than the univariate
model (AIC = 17016.1) (recall, a smaller value indicates a better fit). Notice how the
multivariate model seems to decrease the variability in the random effects. Taking into
account the SE’s for the estimates of variance and covariance the multivariate model, in
general, allows for more accurate prediction, though just slightly.
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Table 21: REML Estimates for the Covariance and Correlation Parameters in the
Univariate and Multivariate Models for the Female Participants

-2 Res ll
AIC

σ2

a1
σa a
1 2
σ2
a2
σa b
11

Covariance Estimates
Correlation Estimates
Univariate
Multivariate Univariate
Multivariate
14396.4
14297.4
14396.4
14297.4
14412.4
14321.4
14412.4
14321.4
138.910 (31.920) 139.820 (31.367)

1.000

1.000

- 142.500 (28.260)

-

0.936

153.230 (33.032) 165.830 (34.286)

1.000

1.000

-7.605 (2.124)

-7.453 (2.058)

-0.886

-0.876

-

-7.776 (1.832)

-

-0.839

0.530 (0.154)

0.518 (0.147)

1.000

1.000

-

-9.157 (2.063)

-

-0.857

-9.626 (2.348)

-10.513 (2.443)

-0.899

-0.903

-

0.603 (0.139)

-

0.9279

σ2

0.747 (0.180)

0.817 (0.188)

1.000

1.000

σ12

47.956 (2.325)

47.645 (2.296) 47.956 (2.325) 47.645 (2.296)

σ 22

44.803 (2.161)

44.407 (2.124) 44.803 (2.161) 44.407 (2.124)

σa b
21
σ2

b1
σa b
12

σa b
2 2
σb b
12

b2

(-2 Res ll = log-likelihood, AIC = Akaike’s information criterion.)

Comparing the fixed effects for the univariate and multivariate mixed-models for
the female participants some interesting things may be considered. First, and foremost,
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there is the question of whether the different models reached the same final conclusion.
Recall, that for the univariate model (Table 12), significant differences were found
between the two METS groups at ages seven through fifteen, for DBP, and eight through
sixteen, for SBP. Compare this to the multivariate model (Table 16), where significant
differences were found between the two METS groups at ages seven through fifteen, for
DBP, and nine through seventeen, for SBP. Essentially the same conclusion was drawn
for both models. Moreover, both the univariate and multivariate models concluded
similarly that no significant differences were found for SBP when using a more
conservative Bonferroni correction, while for DBP there were significant differences at
ages nine through fourteen, and ages nine through thirteen, respectively.
When comparing the two models’ LS means differences (i.e. comparing Table 12
and Table 16), what was even more telling was the precision of these differences. For
each age, not only were the estimates for the differences slightly smaller for the
multivariate model, the SE’s were also slightly smaller, when compared to the univariate
model. The SE’s were further evidence that, when applicable, fitting a joint mixed-effects
model was a better method.
Another item to touch upon was how the covariates compare between the two
types of models. Recall, from section 3.5.3, that both the univariate and multivariate
models did not find significant relationships between either covariate, relative age and
birth weight, and either DBP or SBP. Both models drew the same conclusions with

81

regards to both covariates being related to a nominal increase in SBP and DBP, see Table
22, with the multivariate model, in general, having more precise estimates, as shown by
smaller SE’s and tighter CI’s.

Table 22: Covariate Comparison for Female Subjects
Slope (SE)
Relative Age
Univariate
Multivariate
Birth Weight
Univariate
Multivariate

DBP
95% CI

p-value

Slope (SE)

SBP
95% CI

p-value

0.462 (0.365)
0.024 (0.344)

(-0.255, 1.179)
(-0.651, 0.699)

0.2065
0.9440

0.623 (0.358)
0.611 (0.338)

(-0.079, 1.324)
(-0.052, 1.274)

0.0821
0.0708

1.679 (1.253)
1.511 (1.287)

(-0.818, 4.175)
(-1.054, 4.075)

0.1843
0.2442

0.664 (1.222)
0.814 (1.256)

(-1.770, 3.098)
(-1.687, 3.315)

0.5885
0.5189
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4

Conclusions and Future Work

4.1. Overview of Work
In this thesis, two methods were considered for fitting two response variables measured
longitudinally, a univariate mixed-effects model and a multivariate mixed-effects model.
Jointly modeling multiple response variables, rather than modeling them independently
incorporates additional information into the model that may increase estimation and
prediction accuracy. An exploration into the potential gain by the multivariate model was
motivated by a desire to more accurately indentify when in childhood individuals start to
become at risk for the metabolic syndrome, which they may develop later in adulthood.
In Chapter 1, a discussion of the methodology available in the literature for modeling
both univariate and multivariate longitudinal data was discussed in some detail. Also in
Chapter 1, the metabolic syndrome was introduced and defined along with the specific
aiMetS of the analysis. In Chapter 2 the methodology, for both the univariate mixedeffects model and the multivariate mixed-effects model was discussed. Estimation of the
fixed and random effects was described, along with formal definitions of the association
in the evolution (AOE) of the two response and the evolution in the associations (EOA).
In Chapter 3 the results of the analysis of the Fels Longitudinal Study data was
presented. Specifically, longitudinal trends in the measures of DBP and SBP during
childhood were modeled using univariate and multivariate approaches, and compared
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between those who went on to develop the metabolic syndrome in adulthood and those
who did not. Here, not only were both models presented for male and female subjects, but
the two models were compared (i.e. the models fit for the males subjects were compared
against each other, and the models fit for the female subjects were compared against each
other). An emphasis placed on what was gained by a multivariate mixed-model. Gains in
the ability for the multivariate model to more accurately estimate both the fixed and
random effects were described. In addition, the AOE and the EOA between DBP and
SBP were estimated for both male and female participants. In fact, there was no evidence
in the literature of estimates for the EOA and the AOE of DBP and SBP for children ages
two through eighteen.
It is common practice for researchers to model several outcomes involved in a
disease process independently. The results of this analysis indicated that there is
additional information that can be gained with a multivariate model of the responses that
are interrelated. It is comforting for researchers to know that the same questions
addressed by the univariate model could be addressed with the multivariate model.
However, the multivariate model is able to address these same questions with more
accuracy (smaller standard errors) while also addressing additional questions that may be
of great interest to the researcher, such as the AOE and the EOA of the responses.
Furthermore, researchers are able to use the same software methods such as PROC
MIXED in SAS for fitting multivariate longitudinal data as they currently use for fitting
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univariate longitudinal data. Other reasons researchers may avoid jointly modeling
response measures is that they may be of different types or collected at varying time
points. For example, in HIV patients, one response may be a time-to-event (death)
measure and another may be a continuous measure of CD4 counts. In fact, responses of
different types are able to be jointly modeled under the framework of generalized mixedeffects models and fit using PROC GLIMMIX in SAS. Furthermore, the mixed-effects
model is able to handle missing data relatively well.

4.2. Limitations
While there are several attractions to the multivariate model, there are several
limitations that researchers should be aware of. For one, an issue of dimensionality is
always present. Depending on the way the variance-covariance structure for the randomeffects is defined, increasing the number of response variables can very quickly increase
the number of parameters that the model must estimate. This issue is typically sidestepped with ease using modern computing methods for a multivariate model in which
there are only two or three response variables. However, with increasing response
variables, there is an exponential increase in the amount of computing power necessary to
produce estimates. One such method when dealing with more than three response
variables is a pair-wise approach discussed by Verbeke, et al. (2001). Other concerns
when using a multivariate mixed-effects model include the assumptions made on the
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correlation structure and the variance-covariance structure. For example, relaxing the
conditional independence assumption by allowing correlated errors may cause a
discrepancy due to the inappropriate modeling of the covariance structure. It is always
important to understand what constraints and requirements are being made regarding the
variance-covariance structure.
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6

Appendices

6.1. Details for Data Processing
Creating the data sets (CHILD), (ADULT), and (FINAL) was done using SAS v. 9.2. The
code associated with this process is shown below.

Code for Data Processing
/* READING IN DATA */
;/*********************************************************************
***********************************************************************
Import Data and extract necessary variables
***********************************************************************
***********************************************************************
/;
libname library "c:\AATHESIS\format";
libname LibForm "C:\Documents and Settings\jmthorpe\Desktop\THESIS
WORK\Fels";
options fmtsearch=(LibForm);
Data Libform.test; set Libform.Vcu0608;
run;
Data LibForm.Subset;
set Libform.Vcu0608;
keep
ptno
/*PATIENT ID NUMBER*/
ANsafhand
/*FELS HAND SKELETAL AGE*/
AGE
/*PATIENT AGE*/
SEX
/*PATIENT SEX*/
ANbpd5
/*DIASTOLIC B.P -5th (mmhg)*/
ANbpsys
/*SYSTOLIC B.P. (mmhg)*/
BChdl
/*ALPHA LIPOPROTEIN (C-HDL)*/
BCsglucose
/*SERUM GLUCOSE (mg/dl)*/
BCtrigly
/*TRIGLYCERIDES*/
ANcrabdomili
/*ABOMINAL-iliac (cm)*/
ANcrabdomumb
/*ADOMINAL-umbilicus (cm)*/
ANz_stature
/*Standarized Z-score for Height*/
ANstature
/*Height (cm)*/
ANweight;
/*Weight (kg)*/
run;
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;/*********************************************************************
***********************************************************************
Creating ADULT data set from SUBSET, flag "high" measures
create METS variables for each observation
***********************************************************************
*********************************************************************/;
Data ADULTa;
set Libform.Subset;
/*select only adult obs between 30-75 years*/
if 30 <= age <= 55;
/* Set "High" Trigly */
if BCtrigly >= 150 then Htrigly = 1;
if . < BCtrigly < 150 then Htrigly = 0;
/* Set "Low" hdl measure, MEN */
if SEX = 1 && . < BChdl < 40 then Lhdl = 1;
if sex = 1 and BChdl >= 40 then Lhdl = 0;
/* Set "Low" hdl measure, WOMEN */
if SEX = 2 && . < BChdl < 50 then Lhdl = 1;
if sex = 2 && BChdl >= 50 then Lhdl = 0;
/* Set "High" BPD measure */
if ANbpd5 >= 85 then Hbpd5 = 1;
if . < ANbpd5 < 85 then Hbpd5 = 0;
/* Set "High" BPS measure */
if ANbpsys >= 130 then Hbpsys = 1;
if . < ANbpsys < 130 then Hbpsys = 0;
/* Set single "High" BP measure */
if Hbpd5 = 1 or Hbpsys = 1 then Hbp = 1;
if Hbpd5 = 0 && Hbpsys = 0 then Hbp = 0;
/* Set "High" glucose measure */
if BCsglucose >= 100 then Hglucose = 1;
if . < BCsglucose < 100 then Hglucose = 0;
/* Set Waiste measurements to one variable */
if ANcrabdomili = . then wc = ANcrabdomumb;
else wc = ANcrabdomili;
/* Set "High" waiste measure, MEN */
if SEX = 1 && wc >= 102 then Hwc = 1;
if sex = 1 && . < wc < 102 then Hwc = 0;
/* Set "High" waiste measure, WOMEN */
if SEX = 2 && wc >= 88 then Hwc = 1;
if sex = 2 && . < wc < 88 then Hwc = 0;
/*Two VERY IMPORTANT variables to create are number of RF missing*/
/*(nmiss) and the sum of the RFs (numRF) These will be used to*/
/*create all of the MS variables*/
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if sum(Hbp,Lhdl,Hglucose,Htrigly,Hwc)>0
then numRF=sum(Hbp,Lhdl,Hglucose,Htrigly,Hwc);
nmiss = nmiss(Hbp,Lhdl,Hglucose,Htrigly,Hwc);
/*Exaclty no, one, two, three, four, or five RFs */
XnoRF=.; XoneRF=.; XtwoRF=.;
XthreeRF=.; XfourRF=.; XfiveRF=.;
/*At least one, two, three, four, or five RFs */
ALoneRF=.; ALtwoRF=.; ALthreeRF=.;
ALfourRF=.; ALfiveRF=.;
if nmiss = 4 then do;
if numRF = . then do;
if numRF = 1 then do;

XfiveRF = 0;
ALfiveRF = 0; end;
XnoRF = 0;
ALoneRF = 1; end;

end;
if nmiss = 3 then do;
if numRF = . then do;
if numRF = 1 then do;
if numRF = 2 then do;

XfiveRF = 0; XfourRF = 0;
ALfourRF = 0; ALfiveRF = 0; end;
XnoRF = 0; XfiveRF = 0;
ALoneRF = 1; ALfiveRF = 0; end;
XnoRF = 0; XoneRF = 0;
ALoneRF = 1; ALtwoRF = 1; end;

end;
if nmiss = 2 then do;
if numRF = . then do;

if numRF = 1 then do;

if numRF = 2 then do;

if numRF = 3 then do;

end;
if nmiss = 1 then do;
if numRF = . then do;

if numRF = 1 then do;

XfiveRF = 0; XfourRF = 0;
XthreeRF = 0; ALthreeRF = 0;
ALfourRF = 0; ALfiveRF = 0; end;
XnoRF = 0; XfiveRF = 0;
XfourRF = 0; ALoneRF = 1;
ALfourRF = 0; ALfiveRF = 0; end;
XnoRF = 0; XoneRF = 0;
XfiveRF = 0; ALoneRF = 1;
ALtwoRF = 1; ALfiveRF = 0; end;
XnoRF = 0; XoneRF = 0;
XtwoRF = 0; ALoneRF = 1;
ALtwoRF = 1; ALthreeRF = 1; end;

XfiveRF = 0; XfourRF = 0;
XthreeRF = 0; XtwoRF = 0;
ALtwoRF = 0; ALthreeRF = 0;
ALfourRF = 0; ALfiveRF = 0; end;
XnoRF = 0; XfiveRF = 0;
XfourRF = 0; XthreeRF = 0;
ALoneRF = 1; ALthree = 0;
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if numRF = 2 then do;

if numRF = 3 then do;

if numRF = 4 then do;

ALfourRF = 0; ALfiveRF = 0; end;
XnoRF = 0; XoneRF = 0;
XfiveRF = 0; XfourRF = 0;
ALoneRF = 1; ALtwoRF = 1;
ALfourRF = 0; ALfiveRF = 0; end;
XnoRF = 0; XoneRF = 0;
XtwoRF = 0; XfiveRF = 0;
ALoneRF = 1; ALtwoRF = 1;
ALthreeRF = 1; ALfiveRF = 0; end;
XnoRF = 0; XoneRF = 0;
XtwoRF = 0; XthreeRF = 0;
ALoneRF = 1; ALtwoRF = 1;
ALthreeRF = 1; ALfourRF = 1; end;

end;
if nmiss = 0 then do;
if numRF = . then do;

if numRF = 1 then do;

if numRF = 2 then do;

if numRF = 3 then do;

if numRF = 4 then do;

if numRF = 5 then do;

XfiveRF = 0; XfourRF = 0;
XthreeRF = 0; XtwoRF = 0;
XoneRF = 0; XnoRF = 1;
ALoneRF = 0; ALtwoRF = 0;
ALthreeRF = 0; ALfourRF = 0;
ALfiveRF = 0; end;
XnoRF = 0; XfiveRF = 0;
XfourRF = 0; XthreeRF = 0;
XtwoRF = 0; XoneRF = 1;
ALoneRF = 1; ALtwoRF = 0;
ALthreeRF = 0; ALfourRF = 0;
ALfiveRF = 0; end;
XnoRF = 0; XoneRF = 0;
XfiveRF = 0; XfourRF = 0;
XthreeRF = 0; XtwoRF = 1;
ALoneRF = 1; ALtwoRF = 1;
ALthreeRF = 0; ALfourRF = 0;
ALfiveRF = 0; end;
XnoRF = 0; XoneRF = 0;
XtwoRF = 0; XfiveRF = 0;
XfourRF = 0; XthreeRF = 1;
ALoneRF = 1; ALtwoRF = 1;
ALthreeRF = 1; ALfourRF = 0;
ALfiveRF = 0; end;
XnoRF = 0; XoneRF = 0;
XtwoRF = 0; XthreeRF = 0;
XfiveRF = 0; XfourRF = 1;
ALoneRF = 1; ALtwoRF = 1;
ALthreeRF = 1; ALfourRF = 1;
ALfiveRF = 0; end;
XnoRF = 0; XoneRF = 0;
XtwoRF = 0; XthreeRF = 0;
XfourRF = 0; XfiveRF = 1;
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ALoneRF = 1; ALtwoRF = 1;
ALthreeRF = 1; ALfourRF = 1;
ALfiveRF = 1; end;
end;
keep

ptno ANsafhand AGE SEX Hbp Lhdl Hglucose Htrigly
Hwc ANstature ANweight numRF nmiss XnoRF XoneRF
XtwoRF XthreeRF XfourRF XfiveRF ALoneRF ALtwoRF
ALthreeRF ALfourRF ALfiveRF;

proc freq data = Adulta;
tables
nmiss numRF numRF*nmiss
XnoRF XoneRF XtwoRF XthreeRF XfourRF XfiveRF
ALoneRF ALtwoRF ALthreeRF ALfourRF ALfiveRF;
run;
/**********************************************************************
***********************************************************************
Creating MS variables for each subject
***********************************************************************
*********************************************************************/;
proc sort data = adulta;
by ptno descending ALoneRF age;
run;
data adult1;
set adulta;
by ptno;
if first.ptno = 1;
if ALoneRF = 1 then AgeMS1diag = age;
keep ptno AgeMS1diag ALoneRF;
run;
proc sort data = adulta;
by ptno descending ALtwoRF age;
data adult2;
set adulta;
by ptno;
if first.ptno = 1;
if ALtwoRF = 1 then AgeMS2diag = age;
keep ptno AgeMS2diag ALtwoRF;
run;

run;

proc sort data = adulta;
by ptno descending ALthreeRF age;
data adult3;
set adulta;
by ptno;
if first.ptno = 1;
if ALthreeRF = 1 then AgeMS3diag = age;
keep ptno AgeMS3diag ALthreeRF;
run;

run;

proc sort data = adulta;
by ptno descending ALfourRF age;
data adult4;
set adulta;
by ptno;
if first.ptno = 1;
if ALfourRF = 1 then AgeMS4diag = age;

run;
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keep ptno AgeMS4diag ALfourRF;
run;
proc sort data = adulta;
by ptno descending ALfiveRF age;
data adult5;
set adulta;
by ptno;
if first.ptno = 1;
if ALfiveRF = 1 then AgeMS5diag = age;
keep ptno AgeMS5diag ALfiveRF;
run;

run;

data adultb;
merge adult1 adult2 adult3 adult4 adult5;
by ptno;
run;
proc sort data = adultb; by ptno; run;
;/*********************************************************************
***********************************************************************
Creating CHILD data set from SUBSET
***********************************************************************
*********************************************************************/;
Data Childa;
set Libform.Subset;
keep ptno ANweight;
if Age <.013;
by ptno age;
if first.ptno = 1;
rename ANweight = birthWT;
run;
proc means data = Childa; run;
proc sort data = Childa;
by ptno; run;
Data Childb;
set Libform.Subset;
if 2 <= age < 19;
if ANcrabdomili = . then WC = ANcrabdomumb;
else WC = ANcrabdomili;
rename ANbpd5 = DBP;
rename ANbpsys = SBP;
rename ANsafhand = SKELETALage;
rename BCHDL = HDL;
rename BCsglucose = Glucose;
rename BCtrigly = Trig;
rename ANstature = ht;
rename ANweight = wt;
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if SEX=1 then SBPmu=102.19768+(1.82416*(AGE-10)**1)+(0.12776*(AGE10)**2)+(0.00249*(AGE-10)**3)-(0.00135*(AGE10)**4)+(2.73157*(ANz_stature)**1)-(0.19618*(ANz_stature)**2)(0.04659*(ANz_stature)**3)+(0.00947*(ANz_stature)**4);
if SEX=2 then SBPmu=102.01027+(1.94397*(AGE-10)**1)+(0.00598*(AGE10)**2)-(0.00789*(AGE-10)**3)-(0.00059*(AGE-10)**4)
+(2.03526*(ANz_stature)**1)+(0.02534*(ANz_stature)**2)(0.01884*(ANz_stature)**3)+(0.00121*(ANz_stature)**4);
if SEX=1 then DBPmu=61.01217+(0.68314*(AGE-10)**1)-(0.09835*(AGE10)**2)+(0.01711*(AGE-10)**3)-(0.00045*(AGE-10)**4)
+(1.46993*(ANz_stature)**1)-(0.07849*(ANz_stature)**2)(0.03144*(ANz_stature)**3)+(0.00967*(ANz_stature)**4);
if SEX=2 then DBPmu=60.50510+(1.01301*(AGE-10)**1)+(0.01157*(AGE10)**2)+(0.00424*(AGE-10)**3)-(0.00137*(AGE-10)**4)
+(1.16641*(ANz_stature)**1)+(0.12795*(ANz_stature)**2)(0.03869*(ANz_stature)**3)-(0.00079*(ANz_stature)**4);
ZSBP=(ANbpsys-SBPmu)/10.7128;
ZDBP=(ANbpd5-DBPmu)/10.7128;
PercentileSBP=probnorm(ZSBP)*100;
PercentileDBP=probnorm(ZDBP)*100;
drop ANcrabdomili ANcrabdomumb ANz_stature SBPmu DBPmu ZSBP ZDBP;
run;
proc sort data = Childb;

by ptno age;

data Childc;
merge Childb (in=a) Childa (in=b);
by ptno;
if a;
run;
proc means data = Childc n mean std median min max;
*where DBP > .;
*where SBP > .;
*where HDL > .;
*where Glucose > .;
*where Trig > .;
*where ANcrabdomili >.;
*where ANcrabdomumb >.;
*where WC >.;
*where SkeletalAge > .;
*var age SkeletalAge;
run;
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;/*********************************************************************
***********************************************************************
Combine CHILD and ADULT data sets
***********************************************************************
*********************************************************************/;
proc sort data = Childc;
by ptno age;
run;
proc sort data = Adultb;
by ptno;
run;
data Libform.Childc;
set Childc;
by ptno;
FlagSub = first.ptno;
run;
proc freq data = Childc;
tables ptno;
run;
data Final;
merge Childc (in=a) Adultb (in=b);
by ptno;
if a and b;
FlagSub = first.ptno;
if ALoneRF = 0 then MSgroup = "None";
if ALthreeRF = 1 then MSgroup = "3+";
run;
data LibForm.Final;
set Final;
if DBP ne . && SBP ne . && WC ne . then elegible = 1;
run;
proc means data = Libform.Final n mean std median min max;
where FlagSub = 1;
var ptno sex birthWT;
run;

proc freq data = Libform.Final;
tables Flagsub;
run;
/*There are 528 subjects (from freq above)*/
ods html file = 'C:\AATHESIS\excel.xls';
proc freq data = Libform.Final;
where FlagSub = 1;
tables MSgroup ALoneRF ALtwoRF ALthreeRF ALfourRF ALfiveRF SEX;
run;
ods html close;
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/* Percentage of Male/Female in the None MSgroup */
proc freq data=Libform.Final;
where MSgroup = "None" && FlagSub=1;
tables sex;
run;
/* Percentage of Male/Female in the 3+ MSgroup */
proc freq data=Libform.Final;
where MSgroup = "3+" && FlagSub=1;
tables sex;
run;
/* Age at diagnosis */
proc means data=Libform.Final n mean std;
where MSgroup = "3+" && FlagSub=1;
var AgeMS3diag AgeMS4diag AgeMS5diag;
run;
proc print data = Final; run;
/*Freq above gives "prevelance" for each MS variable*/
/* Setting SBP and DBP to an integer measure */
data Libform.Final;
set Libform.Final;
SBP = int(SBP);
DBP = int(DBP);
run;
data Libform.FinalStacked;
set Final;
value = SBP;
resp = "SBP"; output;
value = DBP;
resp = "DBP"; output;
keep ptno Age Sex MSGroup birthwt Skeletalage value resp ht wt FlagSub;
run;
proc freq data=Libform.FinalStacked;
where MSgroup = "3+" && FlagSub=1;
tables sex;
run;
proc sort data = Libform.FinalStacked;
by resp;
run;

6.2. Details for Mixed-Effects Modeling
Both the univariate and multivariate mixed-effects models were done using PROC
MIXED with using SAS v. 9.2. The code associated with this process is shown below.
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Code for the Mixed-Effects Models
;/*********************************************************************
***********************************************************************
Univariate/Multivariate Mixed-Model Procedure for Male Subjects
***********************************************************************
*********************************************************************/;
proc mixed data = Libform.FinalStacked2 covtest;
Where sex = 1 ;*Males;
class resp ptno MSGroup;
model value =
resp relage birthwt resp*relage resp*birthwt
age MSGroup age*MSGroup resp*age
resp*MSGroup resp*age*MSGroup
age*age age*age*MSgroup age*age*resp
age*age*resp*MSgroup age*age*age
age*age*age*MSgroup age*age*age*resp
age*age*age*resp*MSgroup age*age*age*age
age*age*age*age*MSgroup
age*age*age*age*resp
age*age*age*age*resp*MSgroup
/s ddfm=kr residual;
*G-Matrix;
***Univariate***
*random int age/ sub=ptno type = un group = resp g gcorr;
***Multivariate***;
random resp resp*age / sub=ptno type=un g gcorr;
*R-Matrix;
*Uncorrelated errors;
repeated /type=VC group=resp subject=ptno;
*Correlated errors
*repeated resp /type=un subject=ptno;
*DBP Fixed Effect Tests;
estimate "DBP: relage" relage 1 resp*relage 1 0;
estimate "DBP: birthwt" birthwt 1 resp*birthwt 1 0;
estimate "DBP: lin age" age 1 age*MSgroup 0.5 0.5
age*resp 1 0
age*resp*MSgroup 0.5 0.5 0 0;
estimate "DBP: MS vs noMS"
MSgroup 1 -1
resp*MSgroup 1 -1 0 0;
estimate "DBP: MS vs noMS lin age"
age*MSgroup 1 -1
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age*resp*MSgroup 1 -1 0 0;
age*age 1 age*age*MSgroup 0.5 0.5
age*age*resp 1 0
age*age*resp*MSgroup 0.5 0.5 0 0;
MS vs noMS quad age" age*age*MSgroup 1 -1
age*age*resp*MSgroup 1 -1 0 0;
cub age" age*age*age 1
age*age*age*MSgroup 0.5 0.5
age*age*age*resp 1 0
age*age*age*resp*MSgroup 0.5 0.5 0 0;
MS vs noMS cub age" age*age*age*MSgroup 1 -1
age*age*age*resp*MSgroup 1 -1 0 0;
quar age" age*age*age*age 1
age*age*age*age*MSgroup 0.5 0.5
age*age*age*age*resp 1 0
age*age*age*age*resp*MSgroup 0.5 0.5 0 0
/singular=1;
MS vs noMS quar age" age*age*age*age*MSgroup 1 -1
age*age*age*age*resp*MSgroup 1 -1 0 0
/singular=1;

estimate "DBP: quad age"

estimate "DBP:
estimate "DBP:

estimate "DBP:
estimate "DBP:

estimate "DBP:

*SBP Fixed Effect Tests;
estimate "SBP: relage" relage 1 resp*relage 0 1;
estimate "SBP: birthwt" birthwt 1 resp*birthwt 0 1;
estimate "SBP: lin age" age 1 age*MSgroup 0.5 0.5
age*resp 0 1
age*resp*MSgroup 0 0 0.5 0.5;
estimate "SBP: MS vs noMS"
MSgroup 1 -1
resp*MSgroup 0 0 1 -1;
estimate "SBP: MS vs noMS lin age" age*MSgroup 1 -1
age*resp*MSgroup 0 0 1 -1;
estimate "SBP: quad age"
age*age 1 age*age*MSgroup 0.5 0.5
age*age*resp 0 1
age*age*resp*MSgroup 0 0 0.5 0.5;
estimate "SBP: MS vs noMS quad age" age*age*MSgroup 1 -1
age*age*resp*MSgroup 0 0 1 -1;
estimate "SBP: cub age" age*age*age 1
age*age*age*MSgroup 0.5 0.5
age*age*age*resp 0 1
age*age*age*resp*MSgroup 0 0 0.5 0.5;
estimate "SBP: MS vs noMS cub age" age*age*age*MSgroup 1 -1
age*age*age*resp*MSgroup 0 0 1 -1;
estimate "SBP: quar age" age*age*age*age 1
age*age*age*age*MSgroup 0.5 0.5
age*age*age*age*resp 0 1
age*age*age*age*resp*MSgroup 0 0 0.5 0.5
/singular=1;
estimate "SBP: MS vs noMS quar age" age*age*age*age*MSgroup 1 -1
age*age*age*age*resp*MSgroup 0 0 1 -1
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/singular=1;
*Differences in BP between MS group at each age;
lsmeans resp*MSgroup / diff cl at age=2 singular = 1;
lsmeans resp*MSgroup / diff cl at age=3 singular = 1;
lsmeans resp*MSgroup / diff cl at age=4 singular = 1;
lsmeans resp*MSgroup / diff cl at age=5 singular = 1;
lsmeans resp*MSgroup / diff cl at age=6 singular = 1;
lsmeans resp*MSgroup / diff cl at age=7 singular = 1;
lsmeans resp*MSgroup / diff cl at age=8 singular = 1;
lsmeans resp*MSgroup / diff cl at age=9 singular = 1;
lsmeans resp*MSgroup / diff cl at age=10 singular = 1;
lsmeans resp*MSgroup / diff cl at age=11 singular = 1;
lsmeans resp*MSgroup / diff cl at age=12 singular = 1;
lsmeans resp*MSgroup / diff cl at age=13 singular = 1;
lsmeans resp*MSgroup / diff cl at age=14 singular = 1;
lsmeans resp*MSgroup / diff cl at age=15 singular = 1;
lsmeans resp*MSgroup / diff cl at age=16 singular = 1;
lsmeans resp*MSgroup / diff cl at age=17 singular = 1;
lsmeans resp*MSgroup / diff cl at age=18 singular = 1;
*Comparisons between DBP and SBP (not described in thesis);
estimate "DBP vs SBP: relage" resp*relage 1 -1;
estimate "DBP vs SBP: birthwt" resp*birthwt 1 -1;
run;
;/*********************************************************************
***********************************************************************
Univariate Mixed Model Procedure for Female Subjects
***********************************************************************
*********************************************************************/;
proc mixed data = Libform.FinalStacked2 covtest;
Where sex = 1 ;*Females;
class resp ptno MSGroup;
model value =
resp relage birthwt resp*relage
resp*birthwt
age MSGroup age*MSGroup resp*age
resp*MSGroup resp*age*MSGroup
age*age age*age*MSgroup age*age*resp
age*age*resp*MSgroup
/s ddfm=kr residual;
*G-Matrix;
***Univariate***
*random int age/ sub=ptno type = un group = resp g gcorr;
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***Multivariate***;
random resp resp*age / sub=ptno type=un g gcorr;
*R-Matrix;
*Uncorrelated errors;
repeated /type=VC group=resp subject=ptno;
*Correlated errors
*repeated resp /type=un subject=ptno;

*DBP Fixed Effect Tests;
estimate "DBP: relage"
estimate "DBP:
estimate "DBP:

estimate "DBP:
estimate "DBP:

estimate "DBP:

estimate "DBP:

relage 1
resp*relage 1 0;
birthwt"
birthwt 1
resp*birthwt 1 0;
lin age"
age 1
age*MSgroup 0.5 0.5
age*resp 1 0
age*resp*MSgroup 0.5 0.5 0 0;
MS vs noMS"
MSgroup 1 -1
resp*MSgroup 1 -1 0 0;
MS vs noMS lin age"
age*MSgroup 1 -1
age*resp*MSgroup 1 -1 0 0;
quad age"
age*age 1
age*age*MSgroup 0.5 0.5
age*age*resp 1 0
age*age*resp*MSgroup 0.5 0.5 0 0;
MS vs noMS quad age"
age*age*MSgroup 1 -1
age*age*resp*MSgroup 1 -1 0 0;

*SBP Fixed Effect Tests;
estimate "SBP: relage"
estimate "SBP:
estimate "SBP:

estimate "SBP:
estimate "SBP:

estimate "SBP:

relage 1
resp*relage 0 1;
birthwt"
birthwt 1
resp*birthwt 0 1;
lin age"
age 1
age*MSgroup 0.5 0.5
age*resp 0 1
age*resp*MSgroup 0 0 0.5 0.5;
MS vs noMS"
MSgroup 1 -1
resp*MSgroup 0 0 1 -1;
MS vs noMS lin age"
age*MSgroup 1 -1
age*resp*MSgroup 0 0 1 -1;
quad age"
age*age 1
age*age*MSgroup 0.5 0.5
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age*age*resp 0 1
age*age*resp*MSgroup 0 0 0.5 0.5;
estimate "SBP: MS vs noMS quad age"
age*age*MSgroup 1 -1
age*age*resp*MSgroup 0 0 1 -1;
*Differences in BP between MS group at each age;
lsmeans resp*MSgroup / diff cl at age=2 singular = 1;
lsmeans resp*MSgroup / diff cl at age=3 singular = 1;
lsmeans resp*MSgroup / diff cl at age=4 singular = 1;
lsmeans resp*MSgroup / diff cl at age=5 singular = 1;
lsmeans resp*MSgroup / diff cl at age=6 singular = 1;
lsmeans resp*MSgroup / diff cl at age=7 singular = 1;
lsmeans resp*MSgroup / diff cl at age=8 singular = 1;
lsmeans resp*MSgroup / diff cl at age=9 singular = 1;
lsmeans resp*MSgroup / diff cl at age=10 singular = 1;
lsmeans resp*MSgroup / diff cl at age=11 singular = 1;
lsmeans resp*MSgroup / diff cl at age=12 singular = 1;
lsmeans resp*MSgroup / diff cl at age=13 singular = 1;
lsmeans resp*MSgroup / diff cl at age=14 singular = 1;
lsmeans resp*MSgroup / diff cl at age=15 singular = 1;
lsmeans resp*MSgroup / diff cl at age=16 singular = 1;
lsmeans resp*MSgroup / diff cl at age=17 singular = 1;
lsmeans resp*MSgroup / diff cl at age=18 singular = 1;
*Comparisons between DBP and SBP (not described in thesis);
estimate "DBP vs SBP: relage" resp*relage 1 -1;
estimate "DBP vs SBP: birthwt" resp*birthwt 1 -1;
run;
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